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EXECUTIVE SUMMARY 
 
Chapter 1: Background and introduction 
• Concern with research implementation was a major factor behind the creation of 
the NHS R&D Programme in 1991. In 1994 an Advisory Group was established 
to identify research priorities in this field. The Implementation Methods 
Programme (IMP) flowed from this and its Commissioning Group funded 36 
projects. Funding for the IMP was capped before the second round of 
commissioning. The Commissioning Group was disbanded and eventually 
responsibility for the programme passed to the National Co-ordinating Centre for 
NHS Service Delivery and Organisation R&D (NCCSDO) which, when most 
projects had finished, asked the Health Economics Research Group (HERG) to 
conduct an evaluation. This was intended to cover: the quality of outputs; lessons 
to be learnt about the communication strategy and the commissioning process; 
and the benefits or payback from the projects. As agreed, the evaluation also 
addresses the questions of whether there should be a synthesis of the findings 
from the IMP and any further assessment of payback. 
 
Chapter 2: Methods 
• We adopted a wide range of quantitative and qualitative methods in the 
evaluation. They included: documentary analysis; interviews with key actors; 
questionnaires to the funded lead researchers; questionnaires to potential users; 
and desk analysis. 
 
Chapter 3: The outputs from the programme 
• As in previous assessments of research programmes, we first examined the 
outputs in terms of knowledge production and various items related to capacity to 
conduct further research. Although there was a high response rate to the 
questionnaire to lead researchers (30/36), missing responses mean that the data 
given below are incomplete. In the case of publications, however, we also made 
some use of data previously gathered by the programme office. 
• We attempted to identify publications that were in some way a specific product of 
IMP funding. About half (59) of the publications from the IMP projects are articles 
in peer reviewed journals.  The journal used most frequently for publication, the 
BMJ, is also the one with the highest journal impact factor score of those 
publishing articles specifically from the programme. The recent publication 
  
datesof many articles reduces the value of citation analysis. Nevertheless, one 
article, Coulter et al, 1999, has already been cited on 53 occasions. Important 
publications, including No Magic Bullets (Oxman et al, 1995), are also associated 
with preliminary work undertaken for the IMP to assist priority setting. 
• Fifteen projects, with grants of over £1.3 million, have been awarded to IMP 
researchers by other funders for follow-on studies connected in some way to the 
IMP. We also collected details about some non-IMP researchers who are building 
on the IMP projects. 
• Research training provided in at least nine of the funded IMP projects is 
associated with higher/research degrees, including three MDs and four PhDs, 
that have been awarded or are being completed. 
 
Chapter 4: Disseminating and using the research findings 
• Limited thought had been given by the Implementation Methods Programme to 
dissemination strategies, but many of the individual researchers were active here. 
In response to the questionnaires, lead researchers reported making 92 
presentations to academic audiences and 104 to practitioner/service groups. 
Some lead researchers showed that their effective dissemination led to utilisation 
of the findings. 
• The Commissioning Group gave some thought to the likely use that could be 
made of individual research projects, but there was limited systematic analysis of 
how the findings as a whole would be taken forward. Achieving impact is difficult 
in this complex field and less than a third of lead researchers claimed to have 
done so, but about half thought impact could be expected. Based mainly on 
reports from lead researchers, we give a brief account of how the findings from 
six projects are being utilised. 
• We sent electronic questionnaires to groups of potential users of selected 
projects but this produced a very low response rate. Our postal survey to Heads 
of Midwifery/researchers in perinatal care produced a higher response of 44%. 
Amongst those who did respond, there is quite a high level of knowledge about 
some of the programme’s projects and some level of existing and potential 
utilisation. We suggest, however, that in some cases there are difficulties in 
identifying  how  far  the  respondent’s  focus  is  on  the findings from the original  
 research projects, and it how far it is on the impact of the IMP study that is about 
 ways of influencing the uptake of such findings. Comments from several 
 respondents showed strong support for the cutting edge nature of some of the 
  
 research. Others, however, also indicated why findings might not be utilised by 
 some practitioners. Several respondents advocated greater dissemination of the 
 IMP. 
 
Chapter 5: Comparing applications with outputs 
• We attempted to compare the scores given to project applications with those 
given to projects based on their outputs. This exercise faced various problems. 
The final reports from all completed projects had in theory already been reviewed 
and given scores for their quality and relevance. In practice, not all final reports 
received scores. We added a refinement by giving further scores that 
incorporated the additional information we gathered about both publications and 
any uptake of the research findings.  
• Various limitations meant that we conducted this analysis on just 19 of the 36 
projects. Nevertheless, the wide range of scores given to the outputs from 
projects indicates that some were much more successful than others. Our rather 
limited evidence suggests that there is some correlation between the scores for 
applications and those for outputs but it is small, which could be related to the 
difficulties encountered during commissioning. 
 
Chapter 6: Lessons learnt about the commissioning process 
• Those who established the IMP were aware that it was a different type of 
research field from those previously addressed within the NHS R&D Programme, 
but one regarded nonetheless as important. Within the NHS R&D Programme at 
that time a standard clinical RCT approach was strongly favoured. There was 
also, as ever, a need for quick results. 
• In developing an understanding of implementation the Advisory Group (AG) 
conducted cutting edge analysis, consulted widely and drew on a wide range of 
disciplines. Our interviewees generally took the view that the AG worked well in 
setting priorities and went as far as it could at the time, especially given the time 
constraints. 
• Based on our field work and analysis  we identified a  series of lessons that might  
inform future exercises. More attention was required to ensure that all relevant 
background disciplines were adequately taken into account in setting priorities 
and commissioning research. Some of these processes needed to be given more 
time than was available. Consultation needed to be organised in a sufficiently 
  
selective way to be of maximum benefit in such a complex area. A time-limited 
programme was not the most appropriate way to cover a field such as this. 
• In relation to the commissioning of the projects, we identified issues about the 
composition of commissioning groups and how people from different 
backgrounds (researchers, practitioners, managers and patient representatives) 
should best be involved. 
• In this new field the Commissioning Group (CG) had to work closely with 
applicants to develop some of the research applications. This raised issues about 
how, and when, this process should be handled. 
• Despite its own rationale, and for a variety of reasons, including the disbanding of 
the CG, the Implementation Methods Programme never developed an 
implementation or communication strategy for its own findings.  
• The general conclusion of those who had been involved with the IMP was that it 
worked as well as it could at the time, and that various important projects were 
commissioned. But it was only a start. 
 
Chapter 7: Should a synthesis of the findings from the programme and further 
                   payback analysis be undertaken? 
• From interviews and questionnaires we identified widespread, but not total, 
agreement that there should be some type of synthesis of the findings from the 
IMP. There is more debate about the form such a synthesis should take. There is 
some support for a more limited type of stock taking, but also wider backing for 
the inclusion of many different elements. These could include: a conceptual map 
of the field of research implementation; an exploration of how the findings from 
the IMP fit into the context of research implementation today; and an assessment 
of how far work is still needed in those areas where no projects were funded. One 
possible suggestion that might incorporate much of this thinking is for the 
establishment of a group or commission of leading researchers in the field. Their 
investigation could incorporate all these elements and attempt to show how the 
issues could be advanced. 
• We suggest that further work on assessing the payback from the IMP is probably 
not worthwhile unless it is undertaken as part of a wide-ranging synthesis. 
  
Chapter 8: Conclusions, lessons and recommendations 
• We conclude that the IMP was seen by many of those involved as a new and 
exciting field. Looking back, they were generally positive about what was started 
through the IMP. It commissioned a series of projects that produced some 
important, rigorous, and cutting edge research, at least some of which is making 
an impact. But this is a complex area in which traditional clinical research, health 
services research and the social sciences all have a role to play. A unique set of 
difficulties, as well as opportunities, was faced by those responsible for taking the 
programme forward. The intellectual challenges of constructing a programme to 
cover such a vast area with diverse and sometimes conflicting conceptual and 
methodological perspectives, were compounded by practical problems. These 
included the capping of the programme’s funding and the premature winding up 
of the Commissioning Group. As a result, this complex programme, which 
arguably needed better support than its more clinically orientated predecessors, 
did not receive it at some stages.  Those involved in the programme had a 
considerable task – the difficulties of which were not completely appreciated at 
the time. They are clearer in retrospect and feed into the lessons and 
recommendations presented here, but it is recognised that a programme such as 
the SDO is already adopting some of the steps. 
• In relation to research commissioning and communication strategies for research 
programmes in general, we suggest it could be helpful if protocols were drawn up 
to cover certain potential difficulties. These include the remit and role of the 
various stakeholders represented on commissioning groups and the extent to 
which commissioning groups should be expected to support applicants with their 
proposals. Perhaps the key general lesson from this evaluation is the need for 
research programmes to have a proper communication strategy. This should 
target dissemination at relevant audiences and stress the desirability for contact 
to be made with potential users as early as possible in the process of devising a 
project. 
• Our other recommendations are more specifically relevant when the SDO 
Programme is considering an area such as implementation methods research.  It  
would be desirable for more time to be made available for preparatory work than 
was allowed for the IMP and also scope provided for the programme to be able to 
re-visit issues and learn from early results. It is difficult to incorporate all the 
analysis that is required if a programme is operating in a time-limited way. 
  
• Our conclusion that research implementation is a crucial area for the NHS R&D 
Programme leads to the recommendation that more R&D activity is needed in 
this field in order to assist delivery of some key NHS agenda items. As a 
preliminary step, there is certainly scope for a type of stock taking of the findings 
from the IMP. On balance there seems also to be an argument for conducting a 
synthesis of work in the implementation field that goes beyond a mere collation of 
findings from the specific projects funded. If undertaken, it should fundamentally 
examine the current NHS needs for research on implementation and how they 
could be addressed in the light of the findings from the IMP and elsewhere.  
• Finally, we recommend that more attention should be given to the timing of 
evaluations such as this and that a phased approach should be adopted. 
Furthermore, researchers should be informed at the outset of their project about 
the likely requirements that might be placed upon them in terms of responding to 
requests for information by those conducting an evaluation. 
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CHAPTER 1: BACKGROUND AND INTRODUCTION 
 
1.1  The establishment of the Implementation Methods Programme 
The NHS R&D Programme was established in 1991 partly as a result of concern that 
insufficient benefits were flowing into the NHS from biomedical and health research.  
Various strategies were adopted by the NHS R&D Programme to address this issue. In 
1993 in North East Thames (and later in North Thames) the regional director of R&D, 
Andy Haines, initiated an Implementation Group to commission R&D implementation 
projects (Evans and Haines, 2000). This activity helped encourage the NHS Central 
Research and Development Committee (CRDC) to establish a review of research into 
methods to implement research findings. This review, commencing in 1994, was seen 
as important, underpinning the ‘whole activity’ of the NHS R&D Programme 
(Department of Health, 1995, para.18), and as highly innovative. 
 
The review was conducted by an Advisory Group (AG) chaired by Andy Haines and the 
Implementation Methods Programme (IMP) flowed from this. In April 1995 the Advisory 
Group identified 20 priority topics for research funding. These included issues such as: 
‘why some clinicians but not others change their practice in response to research 
findings’; and ‘effectiveness and cost effectiveness of reminder and decision support 
systems to implement research findings’ (Department of Health, 1995, p. 20). No 
distinction was made between top and further priorities as had been done by some 
other time-limited NHS R&D programmes (Wisely and Haines, 1995). Following the 
work of the Advisory Group, the IMP, like other national time-limited NHS R&D 
programmes, was administered through an NHS regional R&D office, in this case North 
Thames. 
 
Later in 1995 a Commissioning Group (CG) was established with Jeremy Grimshaw 
as chair. Following calls for proposals, in July 1995 and April 1997, a total of 35 
projects was funded and in addition a contribution of £100K was made to the 
Informed Choice Leaflets project. Unlike in previous national programmes, two 
approaches to commissioning were adopted in the first round of funding. In addition 
to the usual two stage process, there was a one stage process for applications under 
£50K. This short application approach ‘was adopted in order to get small studies, 
particularly systematic reviews, underway as soon as possible’ (NHS Executive, 
1996).  
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The invitation resulted in 235 short applications being received; more than had been 
expected. Processing them involved considerable additional work because, even 
after an initial triage, 199 short applications were externally peer reviewed and 
assessed by the CG. In discussing the process, it was argued that although the 
number of applications perhaps demonstrated that the one stage process was 
welcome by applicants, the workload created was large and yet many applications 
had been inappropriately resourced to stay within the £50K limit. Therefore, it was 
recommended in the programme report that:  ‘defining the types of studies permitted 
(e.g. only systematic reviews) as well as giving a funding limit would reduce the 
number of inappropriate applications. In this way studies may be commissioned more 
quickly without the burden on reviewers and the administrative process becoming 
unmanageable’ (NHS Executive, 2000, p.23). 
 
The more traditional two-stage process resulted in 149 outline applications. 
Eventually 69 full applications were peer reviewed and assessed by the CG, but their 
success rate ‘was low and particularly disappointing’ (NHS Executive, 1996) and 
Commissioning Group members were reported to be disappointed that the ideas 
from the outline stage were often not sufficiently developed in the full applications. 
There were concerns about many of the quantitative and qualitative proposals, and 
the concerns about the latter are listed here with the points being further discussed in 
section 6.8: 
• ‘a lack of theoretical underpinning to studies; 
• a lack of detail on how the analysis would be undertaken; 
• that the resources required for undertaking studies were underestimated; 
• that methods inappropriate to the research questions posed were identified’ (NHS 
Executive, 1996). 
  
The IMP had been established with a budget of about £8 million. Half was allocated in 
the first round, although £534K of that was not spent after one study was terminated 
following the feasibility stage. Prior to the second round a funding cap on national R&D 
programmes was announced and in that round just £800K was allocated to three 
projects. The Commissioning Group was disbanded. 
 
 A progress report on the IMP was produced (NHS Executive, 2000) just before 
responsibility for it passed, in 2000, to the National Co-ordinating Centre for NHS 
  3     
Service Delivery and Organisation R&D (NCCSDO). By then, both rounds of 
commissioning, and various projects, had been completed.  
 
1.2  The evaluation of the programme 
The Health Economics Research Group (HERG), Brunel University, had conducted 
evaluations of the benefits from various health R&D programmes, including assessing 
the payback from the North Thames regional R&D programme (Buxton et al, 1999 and 
2000). This had not, however, included the time-limited national programmes 
administered by North Thames. When most of the projects from the IMP had been 
completed, HERG was invited to make a proposal to undertake an evaluation of the 
IMP that would specifically include the quality of the outputs and the commissioning 
process. The aim of the evaluation included seeing what lessons could be learnt for 
future commissioning and communication strategies of the Service Delivery and 
Organisation (SDO) Programme. 
 
Various ways of analysing the publications were identified for the proposed evaluation, 
but in discussions it was agreed that the recent nature of many of the publications from 
the projects would limit the relevance of the citation analysis that would be conducted. 
On the other hand, it was agreed that a small-scale assessment should be included of 
the impact of the IMP on policy and practice in the health service. This would not be as 
extensive as previous payback assessments from HERG. Neither would it fully fulfil the 
original brief of the IMP’s Commissioning Group which included advising on ‘the quality 
and value to the NHS of the programme three and five years after its commencement’ 
(NHS Executive, 2000, p.41—emphasis added).  
 
Our report starts by describing the range of methods used to achieve the various 
objectives. Then Chapters 3 and 4 contain the largely quantitative account of the 
outputs, dissemination and impacts from the projects funded by the programme. These 
chapters reveal how the IMP identified and commissioned projects that have 
successfully produced a quite substantial body of literature, have provided the basis for 
further research and research training, have been widely disseminated, and have 
produced some impact. In Chapter 5, a comparison is made between the scores given 
to applications and those given to the projects for their final reports and subsequent 
outputs.  
 
Many of those involved in the Advisory and Commissioning Groups felt that much had 
been achieved by the various activities. Inevitably, given the newness and evolving 
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nature of the area, and the subsequent capping of the programme funds and truncation 
of its work, there is much to be learnt from the experiences and difficulties 
encountered. The interviews with the members of both groups are drawn together in 
Chapter 6 which details a series of specific lessons related particularly to 
commissioning processes.   
 
Chapter 7 addresses two further issues that were identified in the initial discussions 
between the NCCSDO and the evaluation team. These are whether there should be a 
synthesis of the findings from the programme and how far it would be appropriate and 
feasible to undertake a more substantial assessment of paybacks from the programme.  
 
Finally, in Chapter 8 some conclusions are made and lessons drawn, including ones 
about the conduct of evaluations such as this. 
 
The report’s appendices include a list of the 20 topics identified by the Advisory Group 
and the 36 projects funded. Executive summaries of each project, including those not 
yet complete, are available on the programme’s web site: 
http://www.doh.gov.uk/research/rd3/nhsrandd/timeltdprogs/imp/index.htm 
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CHAPTER 2: METHODS 
 
2.1 A range of methods 
In undertaking this evaluation a mixture of both quantitative and qualitative methods 
was seen as being appropriate. Numerical data about items such as the number of 
articles produced are supplemented by methods that allow the context to be explored 
and the different perspectives of the key actors understood. An early draft of the report 
was submitted to the Director of the NCCSDO for comment. 
 
2.2 Documentary analysis 
In addition to the published documents from the IMP, some review of the IMP’s files 
was also undertaken to help inform analysis of the key issues facing the development 
and work of the IMP. Information was recorded from the project files about: the scores 
given to proposals; potential users of the project identified on the application forms; and 
scores given to end of project reports. 
 
2.3 Interviews 
Throughout the evaluation a phased programme of interviews was conducted, starting 
with the chairs of the Advisory and Commissioning Groups, Andy Haines and Jeremy 
Grimshaw respectively, and with Trevor Sheldon, who acted as Deputy Chair of the 
Commissioning Group on occasions. Then other members of both groups were 
interviewed. All but one of those approached for an interview agreed to participate, and 
the positive attitude displayed by many interviewees reflected the enthusiasm that 
generally seemed to characterise the work of these groups. In total 25 interviews were 
conducted with 24 subjects, mostly face-to-face, but some by phone. A semi-structured 
interview schedule was devised based on the initial reading of the documents and the 
early interviews. 
 
The prime focus of the interviews was on the commissioning process and therefore an 
attempt was made to talk to all those who had been members of this group. Fifteen 
Commissioning Group members were interviewed out of the 20 who served at one time 
or another. Of the remaining five, two had died, two were abroad and one could not be 
located. Some of these 20 were also on the Advisory Group and in total 12 of the 19 
people who served on that group were interviewed, as were two members of the IMP’s 
secretariat. Trevor Sheldon was interviewed again towards the end of the process to 
comment on the emerging findings. The interviews were all recorded, transcribed and 
entered into a database in which the interview schedule provided the coding frame. As 
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is discussed later, quite a few members of the two groups successfully applied for 
funding from the IMP and in some of the interviews specific points about their project 
were also discussed. 
 
2.4  Questionnaires to lead researchers 
A questionnaire was sent to the lead applicants of all 36 projects funded. The 
questionnaire was based on one developed by HERG for the evaluation of the North 
Thames Programme (Buxton et al, 1999; Hanney et al, 1999). The questionnaire had 
been adapted and applied in the evaluation of other NHS time-limited national R&D 
programmes (Wisely, 2001a and b) and was further amended following discussions 
with members of the SDO and piloting by lead researchers from two projects. Some 
helpful amendments were made but the questionnaire retained its basic structure which 
was informed by the HERG payback framework (Buxton and Hanney, 1996). 
Therefore, it started by asking about knowledge production, then examined each 
project’s contribution to research training and further research, and next considered the 
possible impact on health policy (as broadly defined) and practice. Given the limited 
time and resources for the evaluation, and the technical difficulties, no attempt was 
made to move towards assessing final outcomes. Instead the questionnaire finished by 
attempting to analyse features of the way in which the dissemination of the IMP’s 
projects might have contributed to their impact, and the role of the programme as a 
whole.  
 
Shortly after their completion, the commissioning processes of the time-limited national 
NHS R&D programme on the interface between primary and secondary care were 
subject to evaluation by a questionnaire sent to applicants, both successful and 
unsuccessful, and reviewers (Wisely and Haines, 1995). This was not done for IMP, 
and it seemed too late during this evaluation to ask detailed questions on these issues. 
A general question on these issues, however, was included in our wider questionnaire  
to lead researchers. (A full copy of the questionnaire is given as Appendix 3).  
 
The questionnaire was sent out under a covering letter from the Director of the 
NCCSDO and this was repeated to those who had not responded. Following at least 
two further emails or follow-up phone calls to those who still had not replied, the 
eventual response rate was 30/36 (83%). Several of these, however, were completed 
very briefly. Though incomplete, this was higher than the response rate of around 67% 
achieved in the previous evaluations noted above (Buxton et al, 1999; Wisely, 2001a 
and b).  
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2.5  Questionnaires to potential users 
Without an in-depth assessment of benefits from individual projects, along the lines 
previously attempted by HERG, it was always going to be difficult to assess the impact 
of the programme. The problems were compounded by the disparate nature of the 
projects. Efforts were made, nevertheless, both to select projects that could be grouped 
together because of their subject matter, and to identify suitable recipients of a brief 
questionnaire that would contain information about the group of projects. There were a 
series of questions which included asking about whether the recipient had: heard of the 
projects described; read the articles described in the attached abstracts; already been 
influenced by the findings etc. The questionnaires were  aimed at gaining information 
about both dissemination and potential use of the findings. Comments about the 
proposed questionnaires were obtained from: three of the researchers whose projects 
were included; the NCCSDO; and a member of the Commissioning Group.   
 
Electronic questionnaires were sent out using C.H.A.I.N. (the Contacts, Help, Advice 
and Information Network). This is a network designed to facilitate links between 
professionals interested in research or evidence based health care. Two groups within 
C.H.A.I.N. were identified to receive specific questionnaires: people with an interest in 
Women’s Health and those with an interest in the management of heart disease. A 
questionnaire with a similar format was sent using a message board for researchers 
interested in shared decision making. (Abbreviated copies of the questionnaires, from 
which the abstracts - and in one case a letter extract - have been removed, are 
provided as Appendices 4-6). The response rate was very low - only 22 replies to 535 
questionnaires distributed - but nevertheless some useful material was obtained from 
these questionnaires.  
 
An attempt to elicit a larger response was made using a postal version of a similar 
questionnaire to 227 practitioners and researchers in the maternity care field, primarily 
Heads of Maternity units in England and Wales. (See Appendix 7 for the abbreviated 
version). This produced a better response of over 44% from one mailing and, in 
addition to the data about numbers who had read and been influenced by various 
projects, many interesting comments were made.  
 
2.6  Desk analysis 
Various databases were used to make assessments of the quality of the research 
outputs. Citation analysis was undertaken for journal articles using the Science, and 
Social Science, Citation Indices from the Institute for Scientific Information (ISI). For 
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those journals included in the ISI databases, the journal impact factor score was 
recorded. The journal impact factor score for a journal in any given year is the average 
number of citations received that year by papers published in the journal in the two 
proceeding years. The NHS section of the Research Outputs Database (ROD), which 
is now maintained by HERG, contains details about articles that have been funded by 
the NHS/Department of Health in some way, ie through project grants or institutional 
support (NHS Executive/Wellcome Trust, 2001). Where relevant, it was searched to 
see if the publications from the IMP were recorded there.  
 
As far as possible in the analysis attempts were made to draw together material from 
the various methods. 
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CHAPTER 3: THE OUTPUTS FROM THE PROGRAMME 
 
3.1 Publications 
One of the problems facing exercises aimed at identifying the outputs from a research 
programme is that knowledge advances rarely come in neatly contained packages. 
Therefore, it can sometimes seem artificial to attempt to link outputs precisely to 
specific programmes. On the other hand, if the contribution made by a specific 
programme is to be assessed then inclusion criteria should be used to determine the 
boundaries of what is to be analysed. 
  
Previous exercises (Buxton et al, 1999; Wisely, 2001a and b) had revealed problems 
with efforts to get researchers to be accurate about the publications coming from 
specific projects. There had been both over and under counting. The programme report 
compiled in late 1999 listed the projects that lead researchers claimed by then had 
come from the programme (NHS Executive, 2000). An initial review was conducted of 
some of those publications and this indicated that several such articles did not carry 
acknowledgements to funding from the IMP. Therefore, our questionnaire to lead 
researchers contained the publications previously notified. It asked respondents to 
delete any that were not funded, at least in part, by the programme and to state 
whether the programme funding was acknowledged for the publications listed and for 
any subsequent ones. As far as possible, therefore, the analysis here focuses on 
publications that did carry acknowledgements to the IMP, or were ones where 
comments by researchers, on the questionnaire or through subsequent iterations, had 
clarified the position. For those projects where no questionnaire was returned, the 
articles from the 2000 programme report were included only if they contained an 
appropriate acknowledgement. This is likely to have led to a conservative bias 
underestimating the number of publications. 
 
As of autumn 2002 about 120 publications could be associated with the IMP, of which 
59 are articles in peer reviewed journals. More have been submitted. Details about the 
numbers of publications in the various categories are given on Table 3.1.  
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Table 3.1: Publications from the IMP’s 36 projects  
 
Type of publication Number 
Peer reviewed journal article 59 
Journal editorial 3 
Journal letter 2 
Published abstract 15 
Book 2 
Chapter 11 
Non-peer reviewed article 2 
Published conference proceedings 6 
Publicly available full report 6 
Other  14 
TOTAL 120 
 
 
The most frequently used journal is the BMJ which published 11 of the articles. It has 
quite a high journal impact factor score—currently 6.6. [This means that on average 
papers published in the BMJ in 1999 and 2000 received 6.6 citations in 2001]. Such 
a high proportion of papers appearing in this journal probably reflects the quality of 
much of the work undertaken, its relevance to clinicians and the interest shown in 
research implementation issues by the BMJ. Different publication dates make citation 
comparisons particularly difficult over a short time period, but six papers have already 
received 10 or more citations. The most highly cited paper that explicitly comes from 
IMP funding is Coulter et al, 1999, which appeared in the BMJ and had been cited 53 
times by October 2002. [In itself this provides an illustration of the dangers of 
undertaking citation analysis when the period since publication is short: this article 
had received just 37 citations when it was examined, along with a small number of 
others, at the start of the evaluation in March 2002]. 
 
Forty one of the 59 articles appear in journals that are included on the ISI databases, 
ie the Science Citation Index and Social Science Citation Index. Inclusion in the ISI 
databases can be taken as a sign of the quality of a journal, but other factors should 
also be considered. For example, as shown below, The British Journal of Midwifery 
was the most frequently used non-ISI publication vehicle for the IMP’s researchers. 
All seven of the publications in that journal come from the one project, Informed 
Choice Leaflets, which also contributed two of the 11 articles in the BMJ. Some of the 
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respondents to the questionnaire to midwives noted that the articles in The British 
Journal of Midwifery were a reason they knew about the project. And, as we shall 
see, knowledge about the project was quite widespread among Heads of Midwifery. 
 
No separate category was included in the questionnaire for reviews in the Cochrane 
Library and, therefore, the five reviews or protocols identified have been included as 
articles, but they do not have a journal impact factor score. Table 3.2 shows the full 
list of journals in which articles have appeared, the numbers in each, and their journal 
impact factor scores. 
 
Table 3.2: The peer reviewed journals containing articles from the IMP—
number of articles and journal impact factor scores 
 
Journal title Number of articles Impact factor score 
BMJ 11 6.6 
Brit J of Midwifery 7  
J of Advanced Nursing 6 0.8 
Cochrane Library 5  
Brit J of General Practice 4 1.4 
Family Practice 3 1.2 
Int J of Pharmacy Practice 2  
Med Ed 2 1.4 
Qual Saf Health Care 2 1.2 
Soc of Health & Illness 2 1.2 
Evidence Based Nursing 1  
Health Bulletin 1  
Health Expectations 1  
Int J of Nursing Studies 1 0.8 
Int J of Tech Assess in Health Care 1 0.8 
Int J Qual in Health Care 1 1.4 
J of Clinical Nursing 1 0.5 
J of Eval Clin Prac 1 0.8 
J of Nursing Education 1 0.5 
J of Nursing Scholarship 1  
Medical Decision Making 1 2.1 
Postgrad Med J 1 0.4 
Qual Health Research  1 0.8 
Soc Sci Med 1 1.8 
Statist Med 1 1.4 
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TOTAL 59  
According to the lead researchers, and selective confirmatory checking, 49 of the 59 
articles acknowledge programme funding. As one respondent noted, however, some 
of the publications were being submitted at about the time when responsibility for the 
programme was being transferred and it was not entirely clear to researchers what 
acknowledgement it was appropriate to give. The NHS ROD database was also used 
to help identify where IMP, or at least NHS, funding had been acknowledged.1  
 
A range of other publications has resulted from the programme. The book, Informing 
Patients (Coulter et al, 1998), was at one time the King’s Fund’s best selling title: the 
sales figures of over 1300 are seen as excellent for a book in this category.  
 
Analysis was also conducted of a somewhat wider range of publications that could be 
associated with the IMP. These came both from the preliminary work conducted by or 
for the Advisory Group, and from subsequent and concurrent research activity related 
to some of the projects.  
 
To inform the work of the Advisory Group, Andy Oxman was commissioned to update 
an earlier review and this resulted in a publication, No Magic Bullets (Oxman et al, 
1995), that has received 284 citations. It is seen as a major contribution to the 
international literature on research implementation. Important publications have also 
come from other preliminary work. A major book on research implementation, Getting 
Research Findings into Practice (Haines and Donald, 1998), contained some 
chapters related to the IMP, including one based on one of the workshops run for the 
Advisory Group (Oliver et al, 1998). A further example illustrates how attributing 
credit for the work is complex, particularly in the systematic reviews field. A report for 
the Advisory Group was prepared by the editors of the relevant Cochrane Review 
Group - Effective Practice and Organisation of Care. A paper (Bero et al, 1998) by 
the same team in the BMJ series edited by Haines and Donald states that, ‘This 
paper is based on a briefing paper prepared by the authors for the Advisory Group on 
the NHS research and development programme on evaluating methods to promote 
the implementation of research and development’. The  paper in the BMJ has been 
cited 158 times and is therefore another major contribution to the field. However, 
similar papers produced concurrently and subsequently by the same team do not 
refer to the IMP. 
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As noted, it can similarly be difficult to draw precise boundaries around the work that 
should be attributed to the IMP projects. For example, project IMP 11-29 resulted in a 
Cochrane Protocol on educational meetings, workshops and preceptorships to 
improve the practice of health professionals and health care outcomes (Thompson et 
al, 1998). A subsequent systematic review (Davis et al, 1999) refers to this as being 
one of the two previous studies on which the review is based. This subsequent 
review was published in JAMA, which has one of the highest impact factor scores of 
any journal on the ISI databases, and it has been cited 114 times. No specific funding 
acknowledgement to the IMP is given in the JAMA article, and, as a result, it is not 
included in our tables. 
 
Other projects funded by the IMP went to researchers who also were concurrently 
and subsequently conducting various similar pieces of work. While the above 
analysis of publications has attempted to identify those most specifically associated 
with the IMP, it is clearly the case that their IMP project should not be entirely 
divorced from the wider body of work of such researchers. Examples of such projects 
include IMP 15-9 conducted by Martin Eccles and IMP 3-16 by Adrian Edwards. In 
the latter case, the overall body of work included an editorial in JAMA (Edwards and 
Elwyn, 1999).  
 
3.2  Further research 
A total of 15 further projects conducted by researchers who had previously been 
funded by the IMP were seen as in some way following-on from their IMP project. 
The grants for the 10 where figures were given in the questionnaire total over £1.3 
million and some are substantial follow up pieces of research to that funded by IMP. 
One example is the £339,000 MRC funded study for Nicky Cullum and colleagues to 
build on the work conducted in project IMP 2-11 on nurses’ use of research. 
 
Table 3.3 shows the number of follow-on grants, and their value, broken down into 3 
categories describing the contribution of the IMP project to securing the subsequent 
grant--considerable, moderate, small. 
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Table 3.3: The importance of the IMP project to securing further research 
funding 
 
 Considerable Moderate Small Contribution 
not recorded 
Combined 
totals 
Number of 
projects where 
funding known  
 
3 4 3  10 
Total amount  
awarded in each 
category 
 
£678K £576K £60K  £1,314K 
Number of 
projects where 
amount of 
further grant not 
stated 
2 2  1 5 
Total number of 
projects 
5 6 3 1 15 
 
Other IMP researchers are waiting to hear the results of applications. At least six 
other significant projects being conducted by researchers not funded by the IMP 
were also seen as drawing to some extent on projects from the IMP. The contribution 
of the IMP project to this work was assessed as being considerable in one case, 
moderate in two and small in the remaining three. 
 
3.3  Research training 
One of the difficulties facing the IMP was reported to be the lack of research capacity 
in this area. It is, therefore, particularly important to note that at least nine projects 
involved research training. An accepted indicator of such research training is whether 
it has led, or will lead, to higher/research degrees (Buxton and Hanney, 1996).  The 
degrees from these nine projects include four PhDs and three MDs—see Table 3.4 
below which also shows the level of contribution to the research degree that came 
from the IMP project. 
 
Table 3.4: Qualifications gained or expected from involvement in the projects 
 
Qualification Obtained Expected Contribution from IMP project 
Considerable Moderate Small 
MSc 1   1  
MPhil 1  1   
MD 3  2 1  
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PhD 
 4 2 2  
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CHAPTER 4: DISSEMINATING AND USING THE RESEARCH FINDINGS 
 
4.1 Dissemination 
This evaluation was asked to comment on the lessons that could be learnt about 
communication strategies for research programmes. As discussed in Chapter 6, the 
rush to identify topics and commission studies meant that only limited thought was 
given to a dissemination strategy for the IMP and the subsequent history of the 
programme meant there was no co-ordinated approach to dissemination. 
Nevertheless, many of the researchers have been active at an individual project level 
in disseminating their findings. Indeed, much of the publication activity described 
above is part of the dissemination process. Table 4.1 below shows the figures 
supplied by the lead researchers about the presentation of findings. More attention 
was given by research teams to disseminate findings to practitioners/service users 
than to academic audiences. The figures for presentations to practitioners/service 
users include 40 given by Angela Coulter and team about project IMP 4-13, and 20 
by the researchers on the Informed Choice Leaflets project. 
 
Table 4.1: Conference/workshop presentations based on the research findings 
 
Audience Number 
Primarily academic audiences 92 
Primarily practitioner/service user audiences 104 
 
 
Examples of the quality of some of the presentations were reported by lead 
researchers. These include the presentation, An expert at your fingertips, given by 
project IMP R2-34 which was rated as the highest quality abstract at the Society for 
Social Medicine Conference 2002.   
 
Dissemination and its analysis, however, is a complex matter. Previous evaluations 
have shown that it is possible to gather much data about dissemination and then be 
uncertain what to do with it (Buxton et al, 1999). As the classic article by Knott and 
Wildavsky (1980) asked, ‘if dissemination is the answer, what is the problem?’ They 
and others (see Lavis, 2002) show that a large amount of dissemination does not 
necessarily lead to uptake. Therefore in this evaluation, in addition to collecting 
information about total dissemination efforts, we made a specific focus focussed 
specifically on dissemination that seemed to assist with impact. Ten projects 
suggested that liaison with potential users before starting the project was a factor in 
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actual or potential utilisation of the findings, and nine of these also thought that 
liaison during the project was relevant. Similar views were also expressed by 
interviewees. Further examples are described below in the discussion on impact.  
 
4.2 Utilisation of the findings 
The Advisory Group’s report stated that, ‘the overarching need was to identify 
research which was likely to provide the greatest payback to the NHS’ (Department 
of Health, 1995, p.16). At one level these issues were addressed and the review of 
project files revealed extensive claims about both the potential users and the benefits 
that could flow from the projects. Similarly, when completing the questionnaire, the 
lead researchers were generally willing to answer the question about who, when the 
research was commissioned, were seen as potential users of the research. 
Interviews with CG members confirm that some consideration was given to these 
matters as applications were considered. 
 
Things become more difficult when we move on to consider the actual value of the 
IMP, which, as already noted, was part of the brief originally given to the CG. At an 
overall level, many interviewees suggested that the IMP had raised awareness of the 
need to improve the implementation of research (in general) in the NHS, and indeed 
this was one of the reasons why so many participants were keen to be involved with 
this programme. Quantifying such awareness and in particular identifying actual use 
of the IMP findings themselves are more problematic. Partly this is a matter of the 
timing of the evaluation and this issue is addressed in the final section of the report. It 
also, however, reflects more fundamental difficulties related to the problems of 
actually achieving research utilisation, especially from individual projects. 
Furthermore, various interviewees felt that a systematic attempt at identification of 
potential users of the IMP was not something that had received a great deal of 
thought during the work of the Advisory and Commissioning Groups. Several 
interviewees could see the paradox of the whole exercise being so intense, in terms 
of identifying priority topics and commissioning projects, that they could not give 
sufficient thought, at the overall level, to the implementation of research on research 
implementation. 
 
In general, as in other studies, more lead researchers claimed in the questionnaires 
that there was a possibility of future impact than were able to state that there had 
already been impact. This is shown in Table 4.2. 
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Table 4.2: Lead researchers’ opinions about the existing and potential impact 
of their research (n = 30) 
 
Type of impact Answers from questionnaires 
 Yes No Don’t know Blank 
Already impacted on policy 9 15 2 4 
Expect to impact on policy 16 11 0 3 
Already impacted on practice 8 12 5 5 
Expect to impact on practice 17 5 1 7 
 
 
The proportion of projects where the lead researcher is claiming that the project has 
already made some impact, or is likely so to do, is compared on Table 4.3 with the 
figures reported in the evaluations of the North Thames research programme 
(Hanney et al, 1999) and other national R&D programmes (Wisely, 2001a and 
2001b).  
 
Table 4.3:  Proportion of lead researchers claiming an impact on policy and 
practice in four R & D programmes 
 
Type of impact North 
Thames 
(Hanney 
et al, 
1999) 
Primary/ 
Secondary 
Interface 
(Wisely, 
2001 a) 
Mother 
and Child 
Health 
(Wisely 
2001 b) 
Implemen- 
tation 
Methods 
Programme 
Already impacted on policy 41% 35% 27% 30% 
Expected impact on policy 65% 54% 68% 53% 
Already impacted on practice 43% 27% 31% 27% 
Expected impact on practice 63% 48% 44% 57% 
 
Any measure such as this is extremely crude and will be influenced by the time 
elapsed since completion of the projects. While there are problems in relying on self 
completion questionnaires, in the example of the North Thames regional R&D 
programme the figures reported by researchers in questionnaires were consistent, at 
an overall level, with the picture revealed by case studies of a selection of the same 
projects (Hanney et al, 1999). Despite the somewhat unusual nature of many of the 
IMP projects, and the relative newness of the whole field, the figures for perceived 
impact are very much in line with those reported by the other national programmes. It 
seems reasonable to assume that the researchers in the IMP are more likely than 
most to focus on implementation, but are also more cautious in their expectations.  
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In some cases the impact from the projects in the IMP is as yet rather tentative, as 
illustrated by the details given below. The first three examples describe impact in the 
services provided by the respective research teams, or during the research project, 
but where the expectation is that impact will be wider. The next three all describe 
more widespread impact, but in each case there is an important point to note in 
relation to the dissemination of the findings: 
• IMP R2-25, on improving nursing practice and outcomes, gave quite explicit 
examples of change that had occurred in the trial sites and further impact is 
expected. 
• IMP 2-11, on nurses’ use of research information in clinical decision making, has 
influenced various courses or educational programmes provided by the 
researchers at the University of York.  
• IMP 3-5, on communicating risk reduction to patients and clinicians in the 
secondary prevention of ischaemic heart disease, produced findings that have 
directly informed the strategy of the clinical effectiveness group based in the 
department from which the research was conducted and perhaps have had a 
wider impact.  
• Researchers from the Informed Choice Leaflets project have had 
communications from Heads of Midwifery units about their use of the research to 
improve dissemination of information to clients. Furthermore, in discussions 
midwives have told them that the research has influenced their practice. The 
claims about impact from this project are supported by evidence from the 
questionnaires described in the next chapter.  
• IMP 19-15, on the injecting drug taker and the community pharmacist, is claimed 
to have made an impact on Department of Health recommendations of 
involvement of pharmacists in supervising consumption of methadone by opiate 
addicts in treatment, and on practice in this area. Two members of the project 
team were members of the Department of Health Working Group that produced 
new guidelines.  
• IMP 4-13, which analysed a range of information leaflets given to patients, has 
already been described as the project with the most highly cited publication and 
with the largest attempt to present findings to potential users. It is claimed that 
this project was used by the British Heart Foundation to re-write their leaflets. In 
interview, a member of the Commissioning Group referred to the project’s 
findings also being used by another organisation. 
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It is worth stressing that in each of the last three examples above, the utilisation is 
facilitated, at least in part, by an important aspect of dissemination. As noted, these 
aspects include: talking to those most likely to be directly implementing the findings 
and publishing extensively in the journal most relevant to the profession (Informed 
Choice Leaflets); serving on the relevant departmental working group (IMP 19-15); 
and talking to many professional groups and publishing a reader-friendly book (IMP 
4-13).   
Furthermore, the lead researcher of project IMP5-40, on uptake of effective practices 
in maternity units, describes how although the project has only recently had its main 
article published, there are reason for expecting utilisation of the project’s findings. A 
very blunt editorial accompanied the article in the International Journal of Quality in 
Health Care and called for action based on the findings. There has also been 
considerable press coverage of the project. The lead author suggests that interest 
from the public is also likely to put pressure on mangers and professionals, and 
claims press interest is an indicator of public interest. There have been articles/items 
about the project in: The Observer; BBC Radio 4’s Today Programme; ITV’s News at 
Ten; BBC World Service; and Radio Vancouver. This project was included in our 
questionnaire to Heads of Midwifery and researchers in perinatal care. Despite its 
recent publication in a journal that might not necessarily have an enormous 
readership amongst midwives, it was still known by 26 of the 100 respondents - 
though some of these were sites where the project was conducted.  
 
Several lead researchers claimed that their findings, sometimes negative, should be 
taken into account in current policies and practice to a greater extent than was 
probably happening. It was further claimed that several projects came up with 
negative findings because of the greater rigour in these IMP projects than in some 
previous assessments of the various implementation approaches analysed. But it is 
widely recognised that the uptake of negative research findings is particularly 
problematic. These points strengthen the case made later for suggesting further 
work, such as a synthesis, is required to enable this programme to achieve its full 
potential impact. This line of argument is further strengthened by the figures on 
Tables 4.4 and 4.5. These show that as individuals the researchers had some 
awareness of the work of other projects, but that, as yet, being part of a programme 
has not been seen as being particularly important by most lead researchers. 
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Table 4.4: Response to questions about giving attention to any other projects 
from the programme (n = 30) 
 
 Yes No Blank Total number of 
projects read or 
presentations 
attended 
Read results of other IMP projects? 
 
14 11 5 29 
Attended presentation about other 
IMP projects? 
5 20 5 10 
 
 
Table 4.5: Response to question about how far the fact that the project was 
part of a programme had any impact on the project (n = 30) 
   
Degree of impact Number 
Not at all 10 
A little 8 
Moderate 2 
Considerable 5 
Extensive 0 
Left blank 5 
 
 
4.3 Impact on potential users 
As described in Chapter 2, four questionnaires were devised and sent to potential 
users. Each was in an area where several projects could be combined to provide 
material to form a questionnaire. (See Appendices 4-7 for details).  
 
There were three different electronic versions of the questionnaire and these were 
sent to 535 email addresses. Just 22 responses were received overall, and some of 
the replies from the shared decision making bulletin board were from overseas. The 
combined figures are shown in Table 4.6 below: 
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Table 4.6: Total figures from three electronic questionnaires to groups of 
potential users 
 
 Number % of those 
returned 
Questionnaires distributed  535  
Questionnaires returned 22  
Knew about IMP 9 41% 
Heard of at least one project 19 86% 
Read an article from at least one project 18 82% 
Findings from at least one already influenced: 
a) clinical practice 
b)   research 
c)   teaching 
 
3 
10 
11 
 
14% 
45% 
50% 
Findings from at least one project will influence: 
a)   clinical practice 
b)   research 
c)   teaching 
 
9 
14 
14 
 
41% 
64% 
64% 
Findings from at least one project have/will have 
influenced others 
 
15 
 
68% 
 
 
While clearly the response rate is too low to make any generalisations, and may itself 
partly be a reflection of lack of knowledge about the IMP, the replies do provide 
illustrations of instances where there is already some knowledge about the projects 
and some use being made. Furthermore, various interesting observations were 
made. Scepticism was expressed in some questionnaire responses, as indeed it had 
been in some interviews, about the practical use of some of the research projects, 
including some of the RCTs. Nevertheless, several of the shared decision making 
researchers who responded were positive about the contribution of the projects to 
their field. Four projects were included on that questionnaire: IMP 4-21; IMP R2-34; 
IMP 4-13; and IMP 3-16 (see Appendix 6 for details). One of the respondents from 
the USA wrote: “These are very important studies that lead the field. Number 2 [IMP 
R2-34] deserves a special comment. Among the studies included it pushes the 
envelope the most...it will be important to have it widely discussed.”  
 
This response is compatible with our emerging conclusion that the programme is 
making a positive contribution to a field that is now more clearly recognised as 
requiring further and wider work. 
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In an attempt to obtain a better response rate, a postal survey was sent to 207 Heads 
of Midwifery and 20 university researchers in perinatal care. A summary of the 
figures from the 100 out of 227 questionnaires returned (44%) is shown in Table 4.7 
below.  
 
Table 4.7: Total figures from postal questionnaire to Heads of Midwifery and 
university researchers in perinatal care 
 
 Number % of those 
returned 
Questionnaires distributed 227  
Questionnaires returned 100  
Knew about IMP 35 35% 
Heard of at least one project 80 80% 
Read an article from at least one project 68 68% 
Findings from at least one already influenced: 
b) clinical practice 
b)   research 
c)   teaching 
 
54 
8 
20 
 
54% 
8% 
20% 
Findings from at least one project will influence: 
a)   clinical practice 
b)   research 
c)   teaching 
 
73 
14 
24 
 
73% 
14% 
24% 
Findings from at least one project have/will have 
influenced others 
 
73 
 
73% 
 
The response rate is clearly not sufficiently high to provide figures that can be viewed 
as properly representative. Nevertheless, they do suggest that there is a reasonably 
high level of knowledge about the projects. In particular, the project on Informed 
Choice Leaflets was known by more than half of the Heads of Midwifery who replied, 
and most of them had read at least one of the articles about it.2 A few respondents 
pointed out that the questionnaires themselves had provided a good means of 
disseminating information about these projects. In reply to question 9 that invited 
comments on the IMP, the following points were made: 
“Needs to be more widely communicated to ensure readership and awareness. 
Quality newsletter circulated. NB. I have retained the articles to discuss with 
midwives.” 
“I am very impressed with this questionnaire approach, since it has raised my 
awareness – and I considered myself to be quite aware of R&D etc.”  
“I think it needs more publicity.” 
“I was unaware there was such a programme. This is unfortunate as the research 
quoted is very interesting and could positively inform practice.” 
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Given the widespread knowledge about some of the projects, and comments such as 
those above, it seems reasonable to suggest there is quite a considerable interest 
within the midwifery profession in the implementation of research findings. This 
interest would also appear to follow through into practice. About half the respondents 
claimed that their clinical practice was already being influenced by the findings of 
some projects, and about two-thirds thought this would be so in future.  
 
One of the problems when interpreting the level of existing and potential impact is the 
question of what exactly is being referred to when discussing impact in relation to 
projects from the IMP.  It is possible that replies to the questionnaire from some 
respondents related to whether they had been directly influenced by the existing 
research on the substantive topic, rather than whether they had been influenced by 
the conclusions of the IMP project, which examined ways to encourage the 
implementation of this existing research. Nevertheless, 44 midwives thought that the 
findings from, for example, project IMP 5-40, on the uptake of effective practices in 
maternity care, might in future be used in their unit to influence clinical practice. 
There is also an issue of generalisabilty here (and discussed further in section 6.8). 
This concerns whether the IMP projects will have an impact in terms of showing how 
the uptake of research in general can be enhanced, or whether the impact is limited 
to the implementation of findings from specific research applied in specific contexts. 
 
Other midwives explained why the findings of the IMP studies would not impact on 
them. One, for example, expressed opinions also shared by others and stated in 
relation to the three projects respectively (see Appendix 7 for details): “no IT system 
available” for touchscreen information; “policies in line with recommendations 
already” about project IMP 5-40; [informed choice] “leaflets too expensive-no 
budget”. It is worth noting that the leaflets are now available on the web, which 
illustrates the almost constantly changing situation in which this type of analysis of 
implementation is conducted. Furthermore, the full complexity of the issues is 
revealed by one respondent who took a rather different view and commented that the 
Informed Choice Leaflets project “has possibly reduced evidence based practice – it 
discouraged managers from buying the leaflets”. 
 
Drawing together the discussion in this chapter suggests that there has been 
effective communication of the findings from various projects. In some cases 
dissemination to key potential users, and previous liaison with them, seems to be 
linked to a degree of utilisation of the findings. The evidence from the user 
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questionnaires is consistent with that of most interviewees that the programme is less 
well known than individual projects. As we have seen several respondents to the 
questionnaire argued that it was a pity that the IMP had not received more publicity. 
At one level, of course, it might not really matter that people are not aware of the 
programme so long as the projects are making an impact. There is some evidence, 
however, from previous evaluations of national NHS R&D programmes that 
researchers felt their project gained more credibility and attention from being seen as 
part of a national programme (Wisely, 2001a and b). It seems feasible to argue that 
such benefits could be extended through a communication strategy. Indeed, Wisely 
noted the comment from one researcher in the Mother and Child Health Programme 
that a concurrent Department of Health programme was adopting a useful model of 
having all the researchers meet annually and there were plans to draw together 
messages from all 12 funded projects (Wisely, 2001 b).  
 
Furthermore, there could be an argument for claiming that the IMP would have 
benefited even more than other programmes from a communication strategy. In other 
programmes, many of the projects are often in a specific medical field and their 
findings could be appropriately presented at the same routine conferences and 
meetings. This might give such programmes a high profile within the relevant 
research/practitioner networks and communities. No such avenues were available for 
collective presentation of the disparate projects in the IMP.  
 
As far as we are aware, our questionnaires to potential users mark the largest 
aggregation of work from the programme, apart from the programme report in 2000 
and the web site. The comments quoted above from some midwives suggest there 
would be support from potential users for greater dissemination of information about 
the programme. In later chapters of this evaluation, comments from interviewees and 
lead researchers are brought together to demonstrate that the IMP could have 
benefited from a proper communication strategy and would still benefit from some 
collective work. 
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CHAPTER 5: COMPARING APPLICATIONS WITH OUTPUTS 
 
 
5.1  Undertaking the comparisons and the difficulty of doing so 
An attempt was made to compare the grades given to applications at the 
commissioning stage with the outputs from the projects. The purpose of this exercise 
was to see whether it threw any more light on the commissioning process. The 
performance of peer review ‘has seldom been evaluated systematically’, but one 
major study of 2,744 projects funded by the Spanish Health Research Fund 
concluded that, ‘peer review scores of grant applications were significant predictors of 
performance of funded projects’ (Claveria et al, 2000, p.11). Previous evaluations of 
NHS R&D programmes had attempted to undertake a comparison between 
applications and outputs (Wisely, 2001 a and b). 
 
For the exercise described here, as part of the evaluation of the IMP, the scores 
originally given to applications by reviewers were put onto a common scale of 0-10. 
Inevitably, given that these were the funded projects, the scores are generally quite 
high. In the review process for the short applications each project had been scored 
only at an overall level. The full applications had been given a score for quality and 
another for relevance. 
 
The original reviewers of the final project reports had been asked to score the report 
according to quality and relevance. These scores were used as the primary source of 
the scores for outputs given in the evaluation described below. For several reasons, 
however, other information was also used. First, the passage of time and the 
response to our questionnaires to lead authors meant that for many of the projects 
more information was available than had been to the reviewers. Therefore, we 
sometimes made adjustments, based on the criteria set out below, to the scores the 
reviewers had originally given to the final reports. Second, not all the project reports 
had been given scores—in some cases there were only comments. If possible, where 
there were no existing scores for project reports, we gave scores solely on the 
evidence that became available during the evaluation, again using the criteria set out 
below. In these cases, the score was not based on reading the end of project report. 
 
Additional factors taken into account in deciding on the scores to be given here for the 
quality of the outputs include: the number and type of publications; the impact factor 
score of the journals in which articles appear; and the citations achieved. In relation to 
relevance, attention was given to the comments in the questionnaire from lead 
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authors about the impact, or potential impact, of the projects. Negative findings 
present a complication because it is often more difficult for such findings to be 
published and make an impact. This in no way reflects on their quality or their 
potential relevance. Therefore, in this assessment, where projects had resulted in 
negative findings that were not necessarily being implemented, credit was still given if 
the issue seemed to have relevance. Although the procedures described above 
involved an inevitably subjective process, in some ways it perhaps allowed greater 
consistency of comparison to be achieved between the projects. 
 
Various difficulties confronted our attempt to compare the portfolio of projects in an 
overall way that would allow analysis of how far the scores at commissioning stage  
predicted eventual success. In the new field covered by the IMP, various interviewees 
mentioned the difficulty of finding experienced peer reviewers.3 One interviewee 
commented that of all the commissioning groups of which he had been a member, 
this was the one in which the scores given by reviewers varied the most. Several 
interviewees reported strong differences of opinion between members of the 
Commissioning Group about the quality of the applications, as well as their relevance 
to the NHS. In addition to the difficulties referred to above, other difficulties included: 
a) The scales used for grading applications differed from those used for scoring the 
final reports. 
b) Some lead researchers did not return our questionnaire, and others only partially 
completed it—and some projects are not yet complete.  
c) One project—Informed Choice Leaflets—was given a score for its report, but not 
for the application, which was handled by the joint funder. 
d) The time since the projects were completed varies enormously, thus giving 
different amounts of time for impact to have occurred. 
e) There is great diversity within the field and between the types of projects funded. 
 
As a result of these difficulties, at this stage we feel able to present the comparative 
scores for just 19 projects, as described below. 
 
5.2 The scores for applications and outputs 
Tables 5.1 and 5.2 show the scores for applications and outputs for the 19 projects on 
as comparable a basis as possible. The scores for the applications are based on the 
originals, but irrespective of how many scores were given to the applications all have 
been presented using a common scale of 0 -10. The scores for the outputs represent 
the judgement made in this evaluation, as described above and again presented on a 
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scale of 0 – 10. The scores from the original reviewers of the research reports are 
given in brackets where available and they strongly influenced the score given in our  
evaluation. Those with question marks indicate there was a score from one reviewer 
and a comment, but no score, from another.  
 
Table 5.1:  The scores given to applications and outputs from projects funded 
using the short application method 
 
 
Score out of 10 for application 
Scores out of 10 for outputs 
 
Quality  
(original score 
from reviewers) 
Relevance 
(original score from 
reviewers) 
9           10          10 
8             7 (8)            9 (9) 
8             7 (6)            8 (7) 
8             4 (5)            5 (5) 
8             3 (3?)            3 (3?) 
7             5 (4?)            5 (3) 
7             4 (5)            5 (6) 
6             8 (8)            7 (7) 
6             8            7 
6             3            7 
5             6 (6)            4 (4) 
5             4 (4.5)            3 (4?) 
 
 
Table 5.2:  The scores given to applications and outputs from projects funded 
using the full application method 
 
Scores out of 10 for application Scores out of 10 for outputs 
 
Quality 
 
Relevance 
 
Quality 
(original score 
from 
reviewers) 
Relevance 
(original score from 
reviewers) 
10 10             7 (7)            5 (5) 
10 8             7 (7)            8 (8)  
9 8             8 (8)            6 (6) 
9 8             7 (8)            6 (8) 
9 7             6            7 
8 8             6 (5)            5 (5) 
8 4             7 (8)            7 (8) 
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Figure 5.1 plots the correlation between the scores given for applications and those 
for outputs. The application scores taken from Table 5.1 have been doubled to allow 
the level of correlation to be presented for the two sets of figures combined. The 
degree of correlation is quite small at 0.34. 
 
Figure 5.1:  Correlation plot for applications and outputs combining both 
application methods 
0 2 4 6 8 10 12 14 16 18 20
Application
0
2
4
6
8
10
12
14
16
18
20
O
u
tp
u
ts
 
Correlation for figures from Tables 5.1 and 5.2 combined = 0.339 (Some 
evidence of correlation between scores). Simple (ordinary) correlation 
calculation was used. The line of best fit is shown. There are two projects with 
a score of 12 for the application and 15 for the outputs.  
 
 
The difficulties facing this exercise place strong limitations on any conclusions that 
can be drawn. There are, however, some indications that, unlike in previous such 
exercises (Wisely, 2001a), it is not necessarily the projects getting poorer scores that 
are the ones where the lead researcher has not returned a questionnaire. In general, 
perhaps, it is reasonable to suggest that the results from the exercise are broadly 
consistent with two main themes emerging from our evaluation. First, some good 
projects were funded as part of the IMP, but others were much less successful. 
Second, enormous complexities confronted those tasked with determining the topics 
and projects most likely to lead to relevant and quality research in this field. This 
issue is examined in detail in the next chapter. 
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CHAPTER 6: LESSONS LEARNT ABOUT THE COMMISSIONING PROCESS 
 
6.1 Introduction 
The IMP was the last of a series of time-limited national programmes established by 
the NHS R&D Programme.  Previous time-limited programmes had dealt largely with 
clinical subjects such as mental health and cardiovascular disease and the NHS R&D 
Programme as a whole was still, as one interviewee noted, “very clinically 
dominated”.  The dominant research methodologies were randomised controlled 
trials (RCTs) and systematic reviews - widely perceived as the gold standard. 
Another interviewee noted, “the notion of diversity of evidence was probably going 
through its lowest point at that time”. The model adopted in the NHS R&D 
Programme to set priorities and commission research reflected all this.  The main 
emphasis was on providing good quality information on the effectiveness of clinical 
practice, seeking to identify interventions that could be assessed through RCTs.  
 
Those who established the IMP were aware that it was a different type of field from 
those previously covered in the NHS R&D Programme. The group reported that, ‘this 
is a complex field spanning a wide range of behavioural, social science, 
management, science policy and health service research interests’ (Department of 
Health, 1995, p.6). This view was reinforced during consultation on the priorities. One 
key respondent warned of “the need to think beyond the acute medical field with an 
emphasis not just on medical research but on health services research”. The 
Advisory Group (AG) and the Commissioning Group (CG) were established with 
people from a broader range of disciplines than usual, and an set of wide-ranging 
background papers was commissioned for the AG. This was productive: “It [IMP] 
opened up discussion about the relationship between clinical/other research and 
practice in a helpful way”.   
 
However, many interviewees also mentioned their initial naiveté about the difficulties 
they faced, and stressed the amount they themselves learnt in the process:   
“I think at the time we felt we knew a lot more than we now realise we did.”  
“For big new areas like this, one needs to have a good deal more humility about what 
the experts brought in know, and what the research community out there might have 
to offer.” 
 
And, despite extensive interdisciplinary discussion in both the AG and the CG, what 
one interviewee described as a “clinical tendency” remained within the IMP.  This had 
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an impact on priority setting and on the research finally commissioned, although at 
least one interviewee suggested there had been insufficient clinically oriented work. 
 
Those interviewees who were on both groups had difficulty separating what 
happened in connection with which group after all this time.  A complicating factor 
was that there was another group as well, a Steering Group set up to oversee the 
large collaborative trials that it was initially expected that the IMP would commission, 
which met once in June 1995 and was disbanded later that year.  There was cross 
membership between this group, the AG and the CG.  The following analysis does 
not therefore seek to look at lessons that might be learnt from each group separately, 
but rather at what can be learnt from the IMP as whole. 
 
6.2 Context – what influences were there on the Implementation Methods 
Programme and how important were they? 
a) In the NHS 
Influences identified by interviewees and in IMP background papers included: 
- the internal market, the perceived need for an informed market, and the new 
element of competition that the market had introduced into the service; 
- the newness of commissioning (services) and GP fund-holding, and the fact 
that ‘at the time there was considerable emphasis on the role of health 
authorities in managing the healthcare resources for local populations through 
effective commissioning‘ (Evans and Haines, 2000, p. xiii). 
 
Opposing views were expressed about the impact of these influences. Managers 
thought them important, saying that purchasing was what drove the IMP:  “...why are 
we buying more if we don’t know that it works?”  Researchers played them down:  
the NHS context “was a very, very background influence”.  The actual outcome of the 
priority setting exercise supports the second of these views. There was some 
emphasis on commissioning (of services) among the priority areas selected 
(numbers 6, 7 and 8), but the many other topics selected indicate that the NHS 
context was only one of a number of general influences at the time. 
 
A more important and more long-term influence identified by several interviewees 
was the chaos and change in the NHS. Optimistically, members of the 
Commissioning Group thought at the time that  “that was settling down”.  This has not 
happened, and, as more than one interviewee pointed out, continuing change 
remains a key impediment to the successful implementation of research in the NHS - 
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“constant institutional change makes it difficult to get research about getting research 
into practice into practice”. 
 
b) In NHS R&D 
Within the NHS R&D Programme the UK Cochrane Centre and the York Centre for 
Reviews and Dissemination had recently been set up.  The existence of these 
centres had led to pressures to say what was happening to all the research they 
were collating and analysing. A related pressure was the evidence-based medicine 
movement, with its emphasis on individual clinical practice.  As one interviewee 
noted, a key influence was “the importance of implementing research because of the 
R&D Programme”.  Implementation was a hot topic.  There were considerable 
pressures to get some implementation research commissioned quickly, with the AG 
noting that, ‘The CRDC was anxious to take forward work in this important area 
without delay’ (Department of Health, 1995, p.12). 
 
As one of an ongoing series of NHS R&D time-limited national programmes, there 
was an expectation among AG and CG members that the IMP would follow the 
pattern of previous programmes, i.e. it would last for 4 to 5 years with more than one 
round of commissioning, there would be continuing involvement of the CG, and some 
time for reflection.  The terms of reference of the CG (and of the short-lived Steering 
Group set up to oversee large scale collaborative trials) mention a five year 
programme. This expectation influenced priority setting and the first round of 
commissioning. In the event, as noted in our introduction, funding for the IMP was 
capped shortly after the first round of commissioning, and the CG was disbanded.    
 
6.3 An innovative programme – understanding implementation  
Many interviewees noted the challenge, and excitement, of getting to grips with such 
a key area for the NHS and for NHS R&D: “It was cutting edge stuff, nowhere else in 
the world was doing much, let alone commissioning a programme of research on 
implementation”.   But there was a price to pay for this frontier approach - “we hadn’t 
really felt our way into doing this sort of research”.  Some AG members interviewed 
said that they thought at the time that the IMP would provide clearer, more definitive, 
answers than proved to be the case.  But not all AG members were, even then, so 
sanguine.  One had appreciated from the start the difficulties faced: “perhaps we 
needed to do a bit more thought on the complexity that we had unravelled before 
necessarily commissioning all the work”.  
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To support the priority setting exercise there was a consultation exercise, several 
commissioned papers, and four workshops run by AG members. A mapping exercise 
was undertaken to provide a conceptual framework for the AG. There was an 
awareness that in reviewing research need the AG should not be: 
‘too mechanistic, focussing on particular techniques and methods of implementation 
in isolation.  R&D was needed to understand the process of implementation within 
the working environment of the NHS as well as to evaluate particular interventions.  
Study design would need to allow for these complex interactions, within and between 
organisations, professional coalitions and individuals’ (Department of Health, 1995, 
p.23). 
  
In addition the AG incorporated members from a wide range of disciplines, albeit with 
a heavy concentration on people from the health service.  In all this the intention to 
be wide-ranging and innovative is clear.  But did the IMP go far enough? 
 
The research framework described in the AG’s report makes it clear that the research 
approach of choice within the programme was the RCT, although the importance of 
descriptive and observational studies ‘in identifying how and why individuals and 
organisations behave’ (Department of Health, 1995, p.17) is also acknowledged. The 
conceptual map of the field in the same document draws on an understanding of 
implementation, provided by one of the background papers, as ‘processes which aim 
to improve targeted clinicians’ compliance with research based recommendations’ 
(Bero et al, 1995). The focus of this was on interventions to change individual clinical 
practice.  Several interviewees pointed out that this now seems rather reductionist. 
 
The key question here - one raised by more than one interviewee - is whether all the 
relevant background disciplines available to the AG were adequately taken into 
account in setting the priorities:  “given what was known in other areas at that time, 
does this [set of priorities] reflect what was going on in those other areas”.  A related 
question is whether all the relevant background disciplines were adequately taken 
into account in commissioning the research: did the research approaches 
commissioned reflect the full range of methods then available in all those other 
areas? 
 
Some interviewees from social science backgrounds were clear that this was not the 
case. One mentioned the lack of underlying theoretical orientation behind the topic 
areas, suggested that there should have been a reference to the broader theory that 
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was available at the time, and cited a paper contributed to the AG which had little 
apparent impact at the time. And with regard to acceptable research approaches the 
interviewee noted that for the CG “The template was the double blind control 
trial….that restricted the kinds of studies that could be conducted and the kinds of 
answers that could be developed from the research”.  This interviewee was clear that 
key messages from social science disciplines were not fully assimilated, and the 
research approaches of these disciplines were not fully appreciated. 
 
Could it have been different then?  It takes time for research and knowledge to 
advance and to understand the challenges of new areas:  “These things take years 
often, before they settle in your mind”. And since then understandings have changed.  
Looking back many interviewees now feel that neither group fully got to grips with the 
complexities of the field.  Two comments illustrate this: 
“…there was too much ‘does this work?’, ‘does doing guidelines work?’ rather than 
‘what are the processes by which these things happen?’ and so on.  So I think that 
we went too fast on those things and I think it was rather dominated by the rather 
clinical agenda – ‘here are a set of interventions/approaches, let us evaluate them’ 
type of thing.”  
“It is unlikely that these type of questions will in general be answered with ‘if you do 
this then you’ll get that’ answers. It is more about, ‘if you have the following 
understanding you’re more likely to be able to put together things that’ll work’…..in 
some ways the idea of producing results and implementing them is just not the right 
model.  A more evolutionary approach saying ‘we scrape away at the questions and 
we develop better understanding and that moves through into better implementation 
of evidence in the system’ is probably a better model of the world to be holding than  
this rather more ‘find out the facts, do the implementation, the implementation 
happens, happy healthy people’.” 
 
But the general view is also that in setting the priorities the AG worked well, and 
maybe went as far as it could at that time, especially given the time constraints under 
which it operated.  One interviewee commented: 
 “…it could be that given our knowledge of the time, let’s consult and find a whole 
series of areas, a scattergun approach, and some of the areas do seem sensible but 
others less so, and let’s just see who comes up with good projects and go for it and 
try and get some flowers to bloom”. 
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And certainly at the time there was a view among the AG that more might be learnt 
from the next stage, the commissioning process.  One member noted that the AG 
had discussed the methodological implications of many topics but  “we didn’t 
necessarily decide how we wanted to resolve them….maybe we were expecting the 
researchers to do more of that developmental work”.   
 
And at the time there was, also, awareness that this first priority setting exercise was 
only a start.  It represented ‘the beginning, rather than the end, of discussion on the 
best ways of evaluating methods to promote the implementation of research findings 
in the NHS’ (Department of Health, 1995, p.23). 
 
In summary, the IMP was a new programme in a new field, raising new and difficult 
challenges for the NHS R&D Programme and for the associated research 
community.  In retrospect perhaps too much was expected too fast.  Complex areas 
such as this, involving a wide range of disciplines, would benefit from more 
preparatory work, lower initial expectations - especially as regards the pace of the 
programme, and an ability to re-visit and learn from early results.  
 
6.4 Consultation 
The AG followed the standard NHS R&D practice of sending an open letter to about 
a hundred organisations, and also approaching purchasers and providers in the 
service.  Responses were collated by the secretariat and presented to the AG.  The 
intention was to identify NHS research needs.  Many interviewees made criticisms of 
this process, others failed to remember it at all.  One problem identified was that 
some of those consulted failed to understand the nature of this new field of research, 
and responded with suggestions for more research on clinical interventions. Another 
was that such exercises failed to reach grass roots workers in the service: “swathes 
of the NHS…are disenfranchised from it”. And those at the receiving end felt that 
such exercises were “almost a waste of time…it disappears into a black hole”.   
 
With hindsight the AG secretariat suggested in a briefing note that ‘in a difficult area 
like this’ a more selective consultation is needed, possibly using focus groups to 
which the nature of the area could be explained in advance.  This approach was in 
fact used in the AG workshop to discuss consumers as a lever for change, and was 
thought to have worked well and led to the publication described above (Oliver et al, 
1998). 
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More fundamental criticisms of such consultation exercises were also expressed.  It 
was felt that they compound what is researchable and where research need lies, with 
where need lies in the NHS.  The tension between the perceived need for general 
participation and openness in setting the research agenda, and the equal need for 
informed opinion about the nature of big questions in a complex area was also 
mentioned.  One remedy now suggested by the former chair of the AG, Andy Haines, 
was to link the setting of a research agenda for implementation studies to a 
descriptive qualitative research project to identify the important decisions that people 
in the service are making at local level in terms of practice or organisation and why 
they fail or succeed, and whether there is any research evidence for those decisions.  
 
In summary, therefore, the approach adopted to consultation in the IMP was 
generally thought not to have been entirely successful.  A tension between getting 
good informed opinion about research need and also ensuring full participation of all 
stakeholders was identified.  One remedy would be to link research topic priority 
setting to an examination of actual NHS decision-making about how to implement 
change.  
 
6.5 Setting and developing the priority areas – did the IMP attempt to be too 
broad, too ambitious? 
Following the pattern adopted by other NHS R&D Programmes, the AG set 20 
priority areas.  Many interviewees, including some who had been involved in earlier 
programmes, thought this was too many.  One talked about “the enormous canvas 
on which we painted” and matching that to the research capacity available. Others  
noted that “we cast our net too wide”, and that  “ideally what you’d do is do a few and 
build it up… throwing so much money into an area where there is a relatively small 
community was not ideal although it was the way that R&D programmes had to work 
at the time”.   
 
There was also considerable variation among the topic areas.  Many interviewees 
noted that there were some areas in which it had been possible to be clear about 
what was needed and what research approaches might be used, other areas where 
more exploratory work should have been done, and some where it might have been 
too early to fund anything.  As one said: “Some clear priorities…there were lots of 
other areas where probably not enough was known to know what the priorities 
were…”. This interviewee expressed concern that this had led to a bias: “…so I felt 
as a consequence the agenda was dominated by what a small number of people who 
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were immersed in the area thought was the primary research agenda”, and 
suggested an alternative approach: “...if we had the time again I would like to see a 
mix of very specified funding where there was broad agreement that these were 
major objectives and then some much more open and phased funding to allow more 
exploration of what the major issues were”.  
 
But in this new field, it is not clear that it would have been possible to identify exactly 
which priority areas needed this additional initial work before the first round of 
commissioning.  As noted above, one interviewee pointed out:  “maybe a scattergun 
approach was the only way forward at the time”.  The first round of commissioning 
revealed a huge amount of information about the available research capacity and 
about the general difficulties of the field.  Much of this was distilled in the 1996 CG 
paper that was intended to inform later commissioning in exactly the way suggested 
above. This was published in the 2000 programme report (Eccles, 2000). 
 
Other constraints on a more deliberative approach were the pressures to get some 
research in place quickly, mentioned above, and the fact that IMP was a time-limited 
programme.  There was a general view at the time that, having got a budget for 
research in this field, it was important to get something in place, to make a start.  
And, as more than one interviewee pointed out, the fact that the funding for the 
programme was capped and there were only two rounds of commissioning, justifies 
this approach in retrospect.   
 
It also raises another question: if the AG had known that the programme was to be 
capped would it have set the priorities it did?  The interviewee who raised this issue 
thought that this might have made a difference, but neither he nor any of the others 
interviewed speculated further on the nature of that difference. What we do know is 
that, as reported above, several interviewees thought that too many priority areas 
had been chosen. It is, perhaps, not unreasonable to assume that, had it been known 
at the time that the budget was to be restricted, a more restricted set of priorities 
might have been chosen.  Our only other clue as to the possible impact of prior 
knowledge of budgetary restrictions is what actually happened after those restrictions 
had been imposed i.e. the way in which the CG adjusted its plans regarding the 
second round of commissioning (see section 6.8). 
 
In conclusion, therefore, there was a tension in the IMP, as in other time-limited NHS 
R&D programmes, between getting on and getting something done versus a more 
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considered approach.  However, in a new area such as the IMP, a careful 
combination of the two approaches is required.  It is not clear this is achievable in a 
time-limited programme.  This suggests the need for a longer initiative in such an 
important field, possibly as a continuing theme running through the NHS R&D 
Programme. 
 
6.6  Commissioning Research –  composition of the Commissioning Group 
The CG took over and advertised the priorities set by the AG, commissioning a first 
round of research within 6 months. As noted above, the task was considerable. 
Despite the pressures most interviewees felt that the process was well handled, 
although they all remember piles of paper.  
  
One issue frequently raised in interviews was the composition of the CG.  There was 
general agreement on the need to involve NHS managers, clinicians and users in 
setting priorities for the IMP, and therefore on the AG.  But some interviewees 
expressed doubts about the value of some people with these backgrounds on the 
CG—although in fact others of them did, also, have research experience. Insofar as 
the task of that body was to assess the quality of the research there was a general 
view among researchers that this specialised function was best left to the experts, 
the researchers themselves.  Insofar as the task of the CG was also to assess the 
relevance of the research there was less unanimity about how that should be 
handled.  It was clear that tensions had arisen on the CG when research quality (as 
assessed by researchers) and perceived relevance to the NHS (as assessed by 
managers, for example) pulled in opposite directions.   
 
In general the importance of establishing relevance at the commissioning stage was 
accepted, although one interviewee wondered why, if relevance had already been 
established at the priority setting stage, it needed to be re-visited.  But the more 
prevalent concern was about doing so in one meeting as one group. One suggestion 
was to have a separate group of non-researchers acting in some sense as advisors 
to the researchers on the CG, possibly before the assessment for research quality, 
possibly afterwards.   
 
A related issue was the mix of the CG.  Having one consumer or one clinician among 
a large group of researchers left that person unsupported, a lone voice who could be 
ignored, especially if that person was, also, relatively junior.  In relation to the IMP, 
some interviewees thought that a similar problem had arisen for researchers from 
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disciplines outside clinical research.  If their viewpoint was new and strange to the 
rest of the group, they risked being seen as “members of the awkward squad”. 
 
We conclude, therefore, that commissioning groups are required to assess the 
quality of proposed research and its relevance to the NHS, yet those best able to 
undertake the first task are not necessarily those best able to undertake the second.  
Their views may clash, creating tensions on the group. We suggest a solution might 
be to develop protocols with commissioning groups, to be agreed with the group at 
their first meeting, to cover the role and remit of members, taking into account their 
differing backgrounds, skills and experience, and defining the group’s relations with 
others brought in to advise the group in any capacity.  
 
6.7 Commissioning research – interaction with applicants 
The quality of many of the applications received by the CG was poor.  In 
consequence the CG felt that it was necessary to put a lot of effort into developing 
applications, helping to build research teams and providing methodological support.  
Several workshops were held with applicants, and both the CG chairman and several 
members spent considerable amounts of time brokering these arrangements.   
 
There was general, but not complete, agreement about the need for this work.  
Those who queried its value pointed to the (sometimes unfulfilled) expectations 
raised by repeated iterations between applicants and funders, and to the difficulties 
research teams might experience working to briefs that had been developed for them 
by the CG.  Other interviewees also differed about the nature of this process.  Some 
thought that you should not work with teams who had not already developed a strong 
methodological understanding; others thought that this was just where you needed to 
help researchers relatively new to a field.  The CG aimed to fund high quality 
research, and was much concerned about methodological rigour.  Much thought went 
into the development of RCTs, statistical advice was provided, as was advice on 
economic evaluation.  This was regarded by those involved as useful and productive: 
“in terms of behaviour change trials and systematic reviewing, it was important in 
improving understanding of why previous studies were bad, poorly designed, which 
then limited their interpretation and usefulness”.  
 
However, the tension was, as always, establishing the balance between funding only 
work of the highest quality and developing the research capacity.  Should you, in the 
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words of one interviewee, “be prepared to let the excellent be the enemy of the good” 
and, if not, in what circumstances?   
 
Concerns were also raised about the timing of CG/researcher interaction.  Despite 
the acknowledged quality of the inputs, workshops for applicants tended to be 
awkward affairs, with competing teams reluctant to talk in each other’s presence.  
But, equally, several interviewees thought that exploratory workshops earlier in the 
process might not have attracted the full range of relevant disciplines or all potential 
applicants.  
 
In summary, therefore, commissioning groups may find it necessary to provide 
support for research applicants during the commissioning process, especially in 
areas which are relatively new and/or where the existing research capacity is weak.  
There are different views about what form this interaction should take.  We suggest 
that, should the need for such support be anticipated by a group, it should be fully 
discussed by them before commissioning work, and, if necessary, a protocol drawn 
up. If this approach is adopted, it too should be subject to evaluation. 
  
6.8 Commissioning research – were there any unacceptable biases? 
The NHS R&D Programme was young and, as mentioned above, clinically 
dominated.  The IMP was the first programme to look at change and management.  
Interviewees confirm that there was agreement on both the AG and the CG that a 
wide range of research approaches was needed in this field.  They differed on what 
this meant.  One view was that there was a need to make sure that people with, for 
instance, sociological skills were there to help those doing trials on guidelines.  
Another was that there was a need to draw on existing bodies of knowledge in 
various social science disciplines and integrate them with NHS issues. There was a 
perceived need to develop qualitative methodologies.  Others identified a raft of 
issues about the development of RCTs: this led to considerable methodological 
gains, and also to attempts to stretch this approach (too far some thought) to cover 
the many complex questions raised by the IMP.  The IMP did not resolve these 
debates.  But in posing them it did begin to challenge the previous supremacy of 
quantitative approaches, and in particular the RCT, within the NHS R&D Programme. 
 
In the event, however, many of the first round research projects were systematic 
reviews or RCTs, or pilot studies for the latter.  Interviewees are agreed however that 
this did not reflect any undue bias towards those approaches.  Several reasons were 
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suggested for the tendency to fund this sort of work.  These include the context 
discussed above - Cochrane/CRD, EBM, and the general clinical orientation of the 
NHS R&D Programme - and also: 
- the poor quality of many of the qualitative applications.  These were often 
submitted by interested clinicians with little or no research training in 
qualitative research. The opinions expressed in interviews were often 
consistent with the points made, as we noted in our introduction, in the First 
Annual Report (NHS Executive, 1996) about the lack, in many applications, of 
a theoretical underpinning and/or sufficient detail about the proposed 
analytical approach;  
- concerns about generalisability.  Research results in the social sciences can 
have a general theoretical applicability.  Interviewees confirm that both groups 
discussed generalisability, but, as one interviewee noted:  “generalisability of 
different kinds of qualitative research methods looks at different notions of 
generalisability: it’s the complex view.  Rather than saying ‘here’s a result, 
use it there’, it’s ‘here is some understanding, understand the problem’ kind of 
generalisability.  There was probably a bit of naiveté of what we were looking 
for in terms of generalisability and that probably pushed towards trying to 
commission more quantitative, clinical trials type things…because we all as a 
group knew how you would generalise from those kinds of results.”  
- a related “failure to embrace complexity”, a tendency to go for the known and 
more mechanistic approaches and not pursue complex questions in 
unfamiliar territory;  
- the need for research teams working in this field to have good links with the 
NHS.  Existing teams of  clinical trialists tended to have these links already; 
- the fact that, as one interviewee put it, “medics tend to favour RCTs”. 
 
The three projects funded under the special circumstances of the second round of 
commissioning were all large trials.  At this point the CG was working under 
considerable pressure to get the remainder of the capped budget allocated, and 
funded large studies that they thought might make an impact.  Interviewees involved 
in those decisions justified those allocations on those grounds. Whatever the 
reasons, and whatever their justification, the second round of commissioned 
research clearly accentuated the clinical orientation of the IMP. 
 
It might be reasonable to conclude, therefore, that the tendency to clinical research 
that marked the IMP, despite the perceived need at the start to use a full range of 
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appropriate methodologies, had a number of causes.  One that was inherent in the 
programme itself was the newness of the field; an important external pressure was 
the time constraint under which the IMP worked.  Taken together these reinforce the 
need for a more measured approach to new fields of work, as already suggested 
above.  
 
The other bias apparent to an outside observer is the large number of CG members 
who were themselves funded through the programme.  The success rate of their 
applications was considerably higher than that of other applicants.  Concerns about 
this, both ante and post facto, were raised by various AG and CG members with the 
commissioning body.  The response was robust: we need good researchers to help 
us develop this new field, there are very few good researchers available, inevitably 
therefore some will be on one or both these groups; this does not concern us as long 
as due process is followed.  All interviewees assured us that due process had always 
been followed, and that such conflicts of interest are common on other 
commissioning groups.  In parenthesis it is worth noting that these experienced 
researchers were funded in the first round because they were able to develop a good 
proposal which could be funded in the confidence that it would deliver in a timely 
manner. Many of the other applications were, as noted above, of poor quality; many 
required several iterations with the CG.  Had the programme not been capped, and 
had the CG been able to develop the research capacity as they hoped, that 
additional research capacity would have been available in future rounds of 
commissioning. 
 
We conclude that due process was followed, and fully recorded, in dealing with the 
conflicts of interest that arose because CG members also submitted applications to 
the programme. Where conflicts of interest exist within commissioning groups this 
should continue to be the case.  
 
6.9 Identifying users and other concerns 
The need to identify the potential users of IMP research was clear from the outset. In 
this field it was seen as particularly important.   An AG briefing paper put the position 
clearly:  ‘As the AG is concerned with implementation presumably it should set 
something of an exemplar role in the active communication of its own work’. Yet 
when we asked interviewees, many of whom are active researchers in this field and 
therefore potential users of IMP-funded research, if they were aware of the outputs of 
the programme, the majority were not.  And, although individual applicants were 
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asked to identify potential users for their own work, interviewees had no recollection 
of discussions on either the AG or the CG about how the findings of the IMP as a 
whole might be disseminated and implemented.   
 
One interviewee expressed this paradox neatly and speculated on a reason for the 
lack of discussion: 
“As a CG we didn’t really embrace the complexity of seeing how difficult it would be 
to get our findings into practice given that we were in the business of findings into 
practice.”  This he put down to: “the bounded rationality problem that it is difficult 
enough thinking about the generation of evidence, and then thinking about the 
application of evidence into complex service settings was something we didn’t have 
intellectual capacity to worry about”. 
 
Then the funding for the IMP was capped, the CG was disbanded and was no longer 
available to support the programme as anticipated in its terms of reference and 
eventually the programme was moved from North Thames.  Even those who had 
been most enthusiastic at the outset lost touch with the programme and its outputs.  
As one interviewee noted: “…the organisational continuity has gone….there is no 
memory there”.  He continued:  “…the disengagement thing was bad.  In retrospect 
something should have happened around that”. 
 
One result was that the IMP was never able to develop an implementation or 
communication strategy for its own findings. This is despite the points noted in 
Chapter 4 about the need for it possibly being greater than for some other 
programmes. 
 
This disengagement had other consequences as well.  One of the lessons from the 
first round of commissioning was that the research capacity in this field was weak 
and needed to be developed if further work was to be funded in this field. At that time 
regional R&D Directorates were developing programmes to enhance research 
capacity locally through funded fellowships and other schemes.  The possibility of 
engaging with these programmes to develop capacity in this field was recognised.  
But, following the capping of the programme and the disbanding of the CG, no 
strategic links could be developed, although some of the funded research projects 
did support young researchers and provide training on a one off basis. 
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Similarly the CG was no longer around to continue any work on methodological 
development - the work that one interviewee had hoped would emerge from the 
commissioning exercise but which, largely, did not.  Nor, collectively, could it 
contribute to the theory building that many thought was necessary in this complex 
field. Nor could it assess the value of the IMP, or build on the initial start made by the 
AG and develop the research agenda in the way envisaged in its terms of reference.  
Nor could it make strategic links with other NHS R&D programmes to ensure that 
their approach to implementation reflected its own findings. Nor, most importantly, 
could it easily maintain what had been a developing role of providing support to the 
research teams already commissioned.  Some CG members did continue on steering 
groups for individual projects, but there was no overarching oversight.  This gap is 
still apparent today in the time it takes to undertake reviews of some completed IMP 
project reports. 
 
Finally there was a concern that lessons had not been learnt from IMP.  There was a 
danger of re-inventing the wheel because, as one interviewee put it: "this [the IMP] 
was a very good bit of SDO [-type] work”.  
 
In summary, many difficulties arose once the funding for the IMP had been capped 
and the CG disbanded. Continuity was lost and there was no-one to establish a 
general dissemination strategy, liaise with other relevant NHS R&D programmes, or 
develop the programme itself further.  These deleterious consequences might have 
been avoided had there been no disengagement, but these were not unique 
occurrences, and point to the need for more continuity in the development of R&D 
strategies. 
 
6.10  The views of lead researchers 
Supplementing the interviews with AG and CG members, the questionnaires to lead 
researchers also asked for opinions about the commissioning process. Perhaps 
unsurprisingly, given these were the successful applicants, those who commented 
generally did so favourably as illustrated by three examples: 
“There was a day workshop—the methodological content was excellent and entirely 
valuable and helpful.”  
“Jeremy Grimshaw helped refine research questions and suggest an appropriate plan 
for research.” 
“We received useful advice from the commissioning group about aspects of study 
design, and were able to make changes to our proposal to ensure the study fitted in 
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with the broader needs of the programme, and served to complement the other 
commissioned studies.” 
These comments are consistent with the claim in the programme report that the 
commissioning processes were ‘more interactive than those previously employed by 
national programmes’ (NHS Executive, 2000). 
 
Critical comments about the programme were mostly about the later stages. A couple 
of researchers commented on the lack of support with dissemination, and a few on the 
slowness of obtaining feedback from reviewers to whom the NCCSDO submitted the 
final reports. These comments reflect the views of the interviewees and enhance the  
feeling that there had been some loss of ownership or interest in the programme. 
Indeed, one researcher explicitly contrasted what had happened with this programme 
with the supportive role played generally by SDO in relation to the work it commissions. 
 
6.11 Was Implementation Methods Programme successful?– views of Advisory 
and Commissioning Group members 
On the whole, interviewees were positive about their engagement with the IMP. 
Several spontaneously praised the way the activities had been chaired and 
suggested that the way the various events were conducted contributed to their 
success. Looking back, they were generally positive too about what was started 
through the IMP. Typical comments were: 
“It was exciting in that it was the first programme that started to take a hard look at 
how we change practice in a big concerted way and tried to pick off some of the main 
issues.” 
”I thought the process we went through came quite close to giving us the programme 
we were looking for even though with hindsight it wasn’t quite the programme we 
should have been looking for.” 
“…it did seem to me at the time that we had funded research that promised to be 
usable.” 
 
But, as discussed above, there were concerns about the lack of real engagement 
with the social sciences and a feeling among some that this had led to missed 
opportunities, particularly in exploring some of the big questions (including ones 
exemplified in the priority areas that remained unfunded). One illustration of this 
concerns the nature of evaluation, and what the health service and health policy 
makers expect from evaluation.  There was much discussion, at the time and in the 
interviews, about the merits and practicalities of evaluating interventions designed to 
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encourage implementation of research in the service – interventions such as GRiPP 
(Getting Research into Practice and Purchasing).  What emerged from these 
discussions is that what could be done depends on the methodological approach 
people are prepared to endorse and, of course, the resource available (including the 
active engagement of the service).   
 
More generally, the debate about what should be done depends on the value 
attached to studying a set of specific interventions, as opposed to a wider, systems-
based approach that looks at the drivers of change, in general, in organisations 
affecting those who work in them.  The IMP favoured the first of these alternative 
ways of addressing the question of what should be done.  Some interviewees argued 
that that was too limited an approach at the time, and is certainly so now.  That is the 
key debate. 
 
As regards the final outcome of the projects themselves most interviewees were, as 
described above, unable to comment except where they had some personal 
involvement. The final word is best left to one of the interviewees:  
“One thing I feel uncomfortable about is the feeling that somehow ‘we’ve done 
implementation research’.  Even if we had had the full £8 million, we wouldn’t have 
done all this, we’d have started….this was the start of it.  There are good lessons to 
learn from it, there are a whole range of areas that need further work…. we should 
continue to see this as an important component of R&D.” 
 
The general conclusion of those engaged at the time with the IMP is that the 
processes through which it was established were, on the whole, as good as they 
could have been then.  There is general agreement about the “clinical tendency” of 
the programme, and some concerns about the lack of real engagement with the 
social sciences.  This debate continues.  The final lesson reflects what was known by 
those developing the programme at the beginning: the IMP is a start, this is a crucial 
area for the NHS R&D Programme, more work is needed.  
 
 
 
 
 
 
 
  47     
CHAPTER 7: SHOULD A SYNTHESIS OF THE FINDINGS FROM THE 
PROGRAMME BE UNDERTAKEN AND FURTHER PAYBACK ANALYSIS 
CONDUCTED? 
 
7.1 Should there be a synthesis of the findings? 
There was widespread, but not total, agreement from the interviewees that some 
type of synthesis of the findings would be desirable; as one noted: “I would be 
enthusiastic for trying to get more mileage out of the effort that’s been put into this”. 
In the questionnaire to lead researchers, support for a synthesis was not quite so 
strong. Of those who answered this question, two respondents were definitely 
against and another four not sure it would be a good idea—mostly because of the 
disparate nature of the projects. Seven out of the 18 respondents, however, were 
strongly in favour and another five were broadly supportive. The comments included 
the following: 
“Absolutely, a book (possibly with accompanying web-site) would be fantastic.”  
“There should be some attempt to summarise what was learned and to look at the 
implications for policy and practice, which may not yet have been picked up.”  
‘There were parallels, overlaps and generalisable issues from the projects—not to 
synthesise these would be a wasted opportunity.” 
 
Furthermore, as we have seen, the articles describing the overall preliminary analysis 
behind the original programme received many citations. This might suggest that 
syntheses in this area are regarded as particularly useful. 
 
There was considerable support for a synthesis of some sort but interviewees also 
emphasised the importance of clarifying the potential audience or customer. In 
addition, they offered many suggestions about the form a synthesis might take.  
Some described the benefits of drawing together the findings from the projects; some 
also warned of the difficulties of doing this and given the very different nature of the 
projects they wondered whether the task was feasible.  This led one interviewee to 
suggest that rather than a synthesis what was required was more of a ‘stock taking’ 
exercise. There was certainly a widespread view that the IMP had not in the end 
been a comprehensive programme, and that, in terms of the projects commissioned, 
“it would not provide a coherent world view”. This reinforced the general thought that 
any synthesis therefore should involve more than a mere collation of key findings.  
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Suggestions made included: 
- an overview of the systematic reviews and other data produced by the IMP 
projects;  
- an assessment of what the findings meant and what lessons could be drawn 
from them collectively, lessons that might not be as obvious or evident from a 
collation of individual studies;  
- a synthesis of what came from the programme with what else is known now, 
drawing lessons about how things should be taken forward. This could draw 
on but not replicate relevant work done by the Cochrane Collaboration and 
others;  
- an analysis of the areas not commissioned with a discussion of whether work 
should now be done in these areas; 
- an assessment of what might be the appropriate methodologies to use in 
further work in the field; 
- the production of a conceptual map of the whole field of behaviour change.  
 
Many of these comments reflect a growing understanding of the complexity of this 
field and the interviewees’ view that the IMP itself had not, inevitably, been able to 
explore all the relevant conceptual and methodological difficulties in a one-off time-
limited exercise. 
 
One suggestion that might provide a framework to encompass many other comments 
was that a group exercise might be undertaken, and indeed was necessary if all the 
relevant issues were to be adequately addressed.  Six or so leading researchers 
from a range of disciplines could be commissioned to review the field and, with a 
strong secretariat, report on recent advances, on what research it would now be 
feasible to do, and on the best methodological approaches. Within such an exercise: 
- one researcher, or group, could produce a collation of the findings from  the 
projects in the context of what was known at the time. This could possibly 
take the format of an extended version of the type of summary that appears in 
articles, such as those in the BMJ, that state what was known and what is 
added (or not) by each study. A slight extension of this would incorporate 
assessment of key findings emerging from some of the major follow-on 
studies such as that being conducted by the researchers responsible for 
project IMP 2-11.  
- another person could look at the priority topics in which no projects were 
commissioned, exploring how far work is still required in those areas.  
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- others could examine the current situation with regard to research 
implementation, and how far the projects helped bring us to this position and 
how the knowledge fits in with SDO’s wider responsibilities and approaches. 
This also links with the questions about the nature of research 
implementation, the need for an organisational approach, and the issue of 
who now has prime responsibility for implementing research findings in the 
UK. The various positive and negative findings produced through the IMP 
have contributed to a greater understanding of the complexity of this field – 
“our knowledge base now is far more sophisticated than it was then”.  There 
is now more realisation that we are at an early stage of working through many 
of the relevant issues and that moving forward requires many different and 
detailed pieces of work to be used and a range of methodologies adopted to 
build up an overall picture. This analysis could also build on the existing calls 
for further research on implementation, for example Foy et al, 2001. 
 
A related suggestion was that an US National Institutes of Health style consensus 
conference might be set up with a multidisciplinary panel, including some people 
from the service, which invited written and oral evidence from researchers 
commissioned through the IMP and from others known in the field. The key here is, 
in the words of another interviewee, to “learn from the experiences of people who try 
to do this research”.   
 
In summary, a synthesis that clarifies where we are now, rather than just collates the 
findings, is generally thought to be a useful idea.  One interviewee also said that she 
thought the timing was right too:  “Actually some of those big projects will only just 
have finished anyway.  So it wouldn’t be out-of-date. Probably the right time”. 
 
Clearly it would be necessary to ensure that any proposal was not incompatible with 
SDO procedures. For example, the various interview and questionnaire exercises 
that led to this current report could, in this context, perhaps be viewed as at least part 
of the ‘Listening Exercise’ usually conducted by the SDO.  
 
7.2 Should further payback analysis be conducted? 
The HERG evaluation of the IMP was also asked to consider the feasibility and 
desirability of conducting a more detailed assessment of the payback from the 
programme. The evaluation has shown it is even more difficult to undertake this type 
of activity on a programme of disparate projects than it is for individual projects. More 
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intensive techniques would be required if the aim was to get much detail beyond the 
type of general response gathered in the questionnaires used here. If this was to be 
done, one approach would be to concentrate on a small number of ‘tracer’ projects 
(Hanney et al, 2000) chosen from among those projects already identified as having 
something interesting to show. Examples could include the six projects listed in 
Chapter 4 as examples of where the lead researchers had described the impact that 
their project was making. It would probably be important to attempt to explore the 
issue of how far any impact is seen as being from the IMP project as opposed to just 
being linked to the original research findings.  
 
Given, therefore, the nature of the programme plus the fact that the sources of 
funding available to the IMP are no longer in place, it probably is not worth 
considering more payback analysis in its own. It might, nevertheless, be worthwhile 
undertaking payback analysis as part of a more complex synthesis of both where the 
IMP projects had led, and what further work is still achievable.  
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CHAPTER 8: CONCLUSIONS, LESSONS AND RECOMMENDATIONS 
 
8.1 Conclusions 
Various conclusions can be drawn from our evaluation. The remit for the evaluation 
included the request that it provide lessons for the SDO Programme’s future 
commissioning processes and strategies for communicating findings, as well as 
make recommendations about a synthesis of the findings.  Conclusions will be given 
first, followed by some lessons and recommendations - including about the conduct 
of evaluations such as this. The lessons and recommendations are presented under 
several headings. It is recognised that a body such as NCCSDO is already adopting 
some of these steps; to that extent these recommendations endorse the existing 
approach of the SDO Programme. 
 
1. Research implementation was seen as being of key importance by leading 
figures within the health research community, but its comparative newness 
created difficulties as well as generating great interest. The general conclusion of 
those engaged at the time with the IMP is that the processes through which it was 
established were, on the whole, as good as they could have been then. There is 
general agreement about the “clinical tendency” of the programme, and some 
concerns about the lack of real engagement with the social sciences.  Overall, 
most of those involved were generally positive about what was started through 
the IMP. 
2. The IMP identified a series of priority topics and commissioned a portfolio of 
projects that led to a range of important outputs. Various publications, including at 
least 59 articles in peer reviewed journals, came from the projects in addition to 
the several important publications that resulted from the preliminary activity. The 
projects have also provided research training that contributed to at least nine 
higher/research degrees, and contributed in various ways to further research 
grants totalling over £1.3 million.  
3. That almost 20% of the articles have been published in the BMJ can be taken as 
an indication of work of considerable quality. Comments from respondents to our 
questionnaires also indicate how some studies are viewed as producing high 
quality, rigorous and cutting edge research. The quality of the studies, and the 
resulting publications, varies greatly, however, and this variation reflects not only 
the differing skills of the research teams but also suggests that some topics are 
more amenable to research than others. Furthermore, several well-conducted 
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studies produced negative findings that probably deserve more attention than 
they might have received given the publication bias against negative studies. 
4. Certain researchers made considerable efforts to disseminate their findings. Not 
surprisingly, the projects that had most impact were associated with some of the 
researchers who used effective dissemination routes. At the programme level, 
however, there were very limited efforts, despite the subject matter, to 
disseminate the research findings. Furthermore, the whole concept of the 
utilisation of research findings in this area is particularly complex. Nevertheless, 
there is some evidence, from the questionnaires to potential users of the IMP 
projects related to perinatal care, of a reasonable level of awareness of the 
research among potential users, and some degree of existing or potential use of 
the findings. There is also evidence from those questionnaires, however, that 
greater attention to disseminating the existence of the IMP would have been 
welcomed by potential users of the findings.  
5. A unique set of difficulties, as well as opportunities, was faced by those 
responsible for taking the programme forward. The intellectual challenges of 
constructing a programme to cover such a vast area with diverse and sometimes 
conflicting conceptual and methodological perspectives were compounded by 
practical problems. These included the capping of the programme’s funding and 
the premature winding up of the Commissioning Group. As a result, this complex 
programme, which arguably needed better support than its more clinically 
orientated predecessors, did not receive it at some stages. This, perhaps, only 
strengthens the case for saying there would probably also be value in 
undertaking a review/synthesis of the field now in the light of the outputs of the 
programme. 
 
8.2 Lessons and recommendations about research commissioning and 
communication strategies in general: 
• Commissioning groups are required to assess the quality of research applications 
and their relevance to the NHS.  Those best able to undertake the first task are 
not necessarily those best able to undertake the second. Their views may clash, 
creating tensions on the group. When a commissioning group for a programme is 
faced with this situation it might help if protocols were developed, to be agreed 
with the group at their first meeting, to cover the role and remit of members. 
These would take into account the members’ differing backgrounds, skills and 
experience, and define the group’s relations with others brought in to advise the 
group in any capacity. (section 6.6)  
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• Commissioning groups may find it necessary to provide support for research 
applicants during the commissioning process, especially in areas which are 
relatively new and/or where the existing research capacity is weak.  There are 
different views about what form this interaction should take.  This should be fully 
discussed in the CG before commissioning work, and, if necessary, a protocol 
drawn up. (6.7) 
• Due process was followed, and fully recorded, in dealing with the conflicts of 
interest that arose because CG members also submitted applications to the 
programme. Where conflicts of interest exist within commissioning groups this 
should continue to be the case. (6.8) 
• Despite the effective dissemination of some projects within the IMP, various 
interviewees, lead researchers, and potential users suggested that it would have 
been beneficial to have had a communication strategy at programme level. We  
endorse this view, and conclude - more strongly still  - that effective dissemination 
of complex research findings from programmes such as the IMP is more 
achievable if research programmes, and their funding bodies, have 
communication strategies. Such strategies should operate at an overall 
programme level as well as encouraging activities by individual research teams, 
and, in all cases, should carefully target dissemination to those users most likely 
to be receptive to the research findings. Successful practices identified by 
individual projects should also be encouraged, such as the selection of 
appropriate journal outlets adopted by the Informed Choice Leaflets project.  And 
researchers should be encouraged to work closely with potential users even as 
the research is being formulated. Bearing in mind that time-scales for research of 
this type can be lengthy, continuity in the organisation of such research 
programmes, and their associated communication strategies, is also important. 
(4; 6.9; 6.10) 
 
 
8.3 Lessons and recommendations relevant for research activities in the 
implementation or similar fields: 
• The IMP was a new programme in a new field, raising new and difficult 
challenges for the NHS R&D Programme and for the associated research 
community.  In retrospect too much was expected too fast.  Various lessons can 
be drawn for the SDO when it is faced with complex areas such as this, involving 
a wide range of disciplines. Compared with the situation faced by the IMP, a 
future programme in such a field would benefit from: more preparatory work; 
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lower initial expectations - especially as regards the pace of the programme; and 
an ability to re-visit and learn from early results. (6.3)  
• The approach adopted to consultation in the IMP was generally thought to have 
had some weaknesses.  A tension between getting good informed opinion about 
research need and ensuring full participation of all stakeholders was identified.  A 
suggested, and perhaps additional, approach that might address some of the 
problems would be  to link research topic priority setting for implementation 
methods research to an examination of actual NHS decision-making about how to 
implement change. (6.4) 
• In the IMP, as in other time-limited NHS R&D programmes, there was a tension 
between getting on and getting something done versus a more considered 
approach.  In a new area such as the IMP a careful combination of the two 
approaches is required.  It is not clear this is achievable in a time-limited 
programme. This suggests the need for a longer initiative in such an important 
field, possibly as a continuing theme running through the NHS R&D Programme. 
(6.5) 
• The final lesson reflects what was known at the beginning by those involved in 
developing the programme: the IMP is a start. This is a crucial area for the NHS 
R&D Programme and more R&D activity is needed in this field to assist delivery 
of some key NHS agenda items. As a preliminary step there is certainly scope for 
a type of stock taking of the findings from the IMP. On balance there is also an 
argument for conducting a synthesis of work on research implementation that 
goes beyond a mere collation of findings from the specific projects funded. If 
undertaken, it should identify current needs for research and explore how they 
could be addressed in the light of the findings from IMP and elsewhere. Further 
work on assessing the payback from the IMP is probably only worthwhile as part 
of such a wide-ranging synthesis. (7)  
 
8.4 Lessons and recommendations about the conduct of evaluations of 
research programmes: 
• This evaluation has underlined several points made previously to the NHS about 
the timing of such evaluations (Buxton et al, 1999). There has been difficulty in 
getting interviewees to remember details of events that occurred up to eight years 
ago. Similarly, some of the first projects, including some systematic reviews, were 
completed six years ago. Other projects are not yet complete and several are 
only just finishing. Lead researchers responding to the questionnaires we sent 
  55     
them made it clear that more attention should be given to the timing of such 
evaluation activities (see also Wisely, 2001a). All this points to the need for 
phased approaches if maximum benefit is to be gained from evaluations 
(Croxson et al, 2001).  
• At a more detailed level, several steps might assist future evaluations. It would be 
useful if more consistent approaches were used in the scales for scoring 
applications and final reports. It would also be desirable to inform researchers at 
the start of a project what might be expected of them in terms of acknowledging 
the programme funding and responding to requests from those evaluating 
research programmes. 
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ENDNOTES 
 
1. A criticism sometimes made of the ISI database is that it underestimates the 
output in Health Services Research (HSR) (Black and Davies, 1999). The source  
journals used to construct the ROD were extended as a result of the analysis by  
Black and Davies to give greater coverage of HSR (NHS Executive/Wellcome  
Trust, 2001). In the case of the IMP, however, this did not increase the number of  
publications from the programme that were included on ROD.  
 
2. It perhaps should be noted, however, that this was the one project out of the 36  
that was not a specific IMP project, but rather the IMP made a contribution to it. 
 
3. This was also seen to be a problem in the programme on the interface between 
primary and secondary care (Wisely and Haines, 1995). 
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Appendix 1: Priority Topics Identified by the Advisory Group 
 
1. Influence of source and presentation of evidence on its uptake by  
health care professionals and others 
 
2. The principal sources of information on health care effectiveness used  
by clinicians 
 
3. The management of uncertainty and communication of risk by  
clinicians 
 
4. Roles for health service users in implementing research 
 
4. Why some clinicians but not others change their practice in response to 
research findings 
 
6. The role of commissioning in securing change in clinical practice 
 
7. Professional, managerial, organisational and commercial factors  
associated with securing change in clinical practice, with a particular  
focus on trusts and primary care providers 
 
8. Interventions directed at clinical and medical directors and directors of 
nursing in trusts to promote evidence-based care 
 
9. Local research implementation and development projects (such as  
GRiPP) 
 
10. Effectiveness and cost-effectiveness of audit and feedback to promote 
implementation of research findings 
 
11. Educational strategies for continuing professional development to  
promote the implementation of research findings 
 
12. Effectiveness and cost-effectiveness of teaching critical appraisal skills  
to clinicians, patients/users, purchasers and providers to promote  
uptake of research findings 
 
13. The role of undergraduate (pre-qualification) training in promoting the  
uptake of research findings 
 
14. The impact of clinical practice guidelines in disciplines other than  
Medicine 
 
15. Effectiveness and cost-effectiveness of reminder and decision support 
systems to implement research findings 
 
16.  The role of the media in promoting uptake of research findings 
 
17. Impact of professional and managerial change agents (including  
educational outreach visits and local opinion leaders) in implementing  
research findings 
 
18. Effect on evidence - based practice of general health policy measures 
 
19. The impact of national guidance to promote clinical effectiveness 
 
20. The use of research-based evidence by policy makers  
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Appendix 2: Studies Commissioned by the Implementation Methods 
Programme 
 
Imp M 1-11 ARMSTRONG 
 
Project title:  A qualitative study of GP's reasons for changing or not  
changing their prescribing behaviour in two areas 
 
Lead researcher: Dr David Armstrong, United Medical and Dental School 
 
 
Imp M 2-11 CULLUM 
 
Project title:   Nurses' use of research evidence in decision-making: a  
descriptive and analytical study  
 
Lead researcher:  Dr Nicky Cullum, University of York 
 
 
Imp M 3-5 FEDER 
 
Project title:   Communicating risk reduction to patients & clinicians in the  
   secondary prevention of ischaemic heart disease: perspectives  
   of inner city patients, general practitioners and practice nurses 
 
Lead researcher:  Dr Gene Feder, St. Bartholomew's & the Royal London  
School of Medicine and Dentistry 
 
 
Imp M 3-10 WYATT 
 
Project title:   Investigation of Doctors' ability to understand and use clinical  
   prognostic models when different metrics are used to describe  
   model performance  
 
Lead researcher: Dr Jeremy Wyatt, University College London 
 
 
Imp M 3-12 BISSELL 
 
Project title:   Self-medication and the communication of risk: the case of  
   deregulated Medicines 
 
Lead researcher:  Mr Paul Bissell, University of Manchester 
 
 
Imp M 3-16 EDWARDS 
 
Project title:   A systematic review of risk communication - improving  
   effective clinical practice and research in primary care 
 
Lead researcher:  Dr Adrian Edwards, University of Wales College of  
Medicine 
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Imp M 4-13 COULTER 
 
Project title:   Availability of information materials to promote evidence-based  
   patient choice 
 
Lead researcher: Professor Angela Coulter, King's Fund 
 
 
Imp M 4-16 GANN 
 
Project title:   Increasingly effective? Evaluating improvements in the ability  
of health information services to provide information on clinical  
effectiveness 
 
Lead researcher: Dr Robert Gann, The Help for Health Trust 
 
 
Imp M 4-21 SMITH 
 
Project title:  Effective communication: an evaluation of touchscreen  
displays for providing information on prenatal diagnosis 
 
Lead researcher: Dr A Pat Smith, Aberdeen Royal Hospitals NHS Trust 
 
 
Imp M 5-23 YATES 
 
Project title:  Understanding the reasons for change, or not, in clinical  
practice - the case of dilatation and curettage 
 
Lead researcher: Dr John Yates, University of Birmingham 
 
 
Imp M 5-40 HEWISON 
 
Project title:  Uptake of effective practices in Maternity Units 
 
Lead researcher: Dr Jenny Hewison, University of Leeds 
 
 
Imp M 5-41 NEWTON 
 
Project title:  Social networks and the use of research in clinical practice 
 
Lead researcher: Dr Elizabeth West, RCN Institute/University of Oxford 
 
 
Imp M 10-11 SCHOFIELD 
 
Project title:   Evidence based secondary prevention of heart disease in  
   primary care: a randomised controlled trial of three methods of  
   implementation (The ASSIST trial)  
 
Lead researcher:  Dr Michael Moher, University of Oxford 
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Imp M 10-16 BAKER   
 
Project title:  The format of recommendations trial: a study of the  
   effectiveness and costs of guidelines, prioritised audit criteria,  
   and feedback in implementing change 
 
Lead researcher: Professor Richard Baker, University of Leicester 
 
 
Imp M 11-10 ROGERS 
 
Project title:  A randomised trial of the effectiveness of strategies directed  
   towards education & implementation and the adoption of  
   evidence based development in primary care 
 
Lead researcher: Dr Stephen Rogers, University College London & Royal  
Free Hospital Schools of Medicine 
 
 
Imp M 11-26 McINTOSH 
 
Project title:  Using informal learning in the implementation of research  
   Findings 
 
Lead researcher: Ms Aileen McIntosh, University of Hull 
 
 
Imp M 11-29 FREEMANTLE 
 
Project title:  The effectiveness of continuing education conferences and  
   workshops to improve the practice of health professionals 
 
 
Lead researcher: Mr Nick Freemantle, University of York 
 
 
Imp M 12-08 DEEKS 
 
Project title:  Systematic review of studies of effectiveness of teaching  
critical Appraisal 
 
Lead researcher: Mr Jonathan Deeks, University of Oxford 
 
 
Imp M 12-09 TAYLOR 
 
Project title:  A randomised controlled trial of the effectiveness of critical  
   appraisal skill workshops on health service decision makers in  
   the South & West region 
 
Lead researcher: Dr Rod Taylor, London School of Hygiene & Tropical  
Medicine 
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Imp M 14-32 THOMAS 
 
Project title:  Systematic review of the effectiveness of guidelines in  
   professions allied to medicine 
 
Lead researcher: Dr Lois Thomas, University of Newcastle Upon Tyne 
 
 
Imp M 15-4 LOGAN 
 
Project title:  A randomised trial of a simple prompting system in promoting  
   appropriate management of iron deficiency anaemia and its  
   influence on clinical outcome 
 
Lead researcher: Dr Elizabeth C M Logan, The King’s Mill Centre for Health 
                                   Care Services 
 
 
Imp M 15-8 WALTON 
 
Project title:  The effectiveness of computerised advice on drug dosage in  
   improving prescribing practice: Systematic review of  
   comparative studies 
 
 
Lead researcher: Dr Robert Walton, Bury Knowle Health Centre 
   (Imperial Cancer Research Fund General Practice  
Research Group, University of Oxford) 
 
 
Imp M 15-9 ECCLES 
 
Project title:  An evaluation of computerised guidelines for the management  
of two chronic conditions 
 
Lead researcher: Professor Martin Eccles, University of Newcastle Upon  
Tyne 
 
 
Imp M 15-11 WYATT 
 
Project title:  A Cochrane systematic review of the effects of paper and  
   computer-based reminders and decision support on clinical  
   practices and patient outcomes 
 
Lead researcher: Dr Jeremy Wyatt, University College London 
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Imp M 15-12 THAPAR 
 
Project title:  Comparing a patient held prompt and reminder card to a doctor  
   held prompt and reminder card to improve epilepsy care in the  
   community: The PRIME (Prompts and Reminders In the  
   Management of Epilepsy) Card Study 
 
Lead researcher: Dr. Ajay Thapar, University of Manchester  
 
 
Imp M 15-19 BOWNS 
 
Project title:  Maternity Guidelines Implemented on Computer - (MaGIC) 
 
Lead researcher: Dr Ian Bowns, University of Sheffield Medical School 
 
 
Imp M 15-21 SZCZEPURA 
 
Project title:  Systematic review of economic studies of reminders and  
   decision support systems 
 
Lead researcher: Dr Ala Szczepura, University of Warwick 
 
 
Imp M 16-18 FREEMANTLE 
 
Project title:  Are mass media campaigns effective in influencing uptake of  
   appropriate health care by health professionals & the general  
   public? A systematic review of available evidence 
 
Lead researcher: Mr Nick Freemantle, University of York 
 
 
Imp M 16-19 PHILO 
 
Project title:  The role of the media in public and professional understanding  
   of breast cancer 
 
Lead researcher: Dr Jenny Kitzinger, Brunel University 
 
 
Imp 17-12 GRIMSHAW  
 
Project Title:  Is the Involvement of Opinion Leaders in the Implementation of  
   Research Findings a Feasible Strategy?  
 
Lead researcher : Professor Jeremy Grimshaw, University of Aberdeen 
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Imp M 17-13 GRIMSHAW 
 
Project title:  Prevention of deep vein thrombosis: A feasibility study for a  
   randomised trial of three different strategies to implement  
   evidence based guidelines 
 
Lead researcher: Professor Jeremy Grimshaw, University of Aberdeen 
 
 
Imp M 19-15 STRANG 
 
Project title:  The injecting drug taker & the community pharmacist: impact of  
   new DoH guideline, and obstacles to a broader service- 
   providing base 
 
Lead researcher: Professor John Strang, National Addiction Centre  
(Institute of Psychiatry) 
 
 
Informed Choice Leaflets  
 
Project title:  Informed Choice in Maternity Care: An Evaluation of Evidence  
   Based Leaflets 
 
Lead researcher: Professor Mavis Kirkham, University of Sheffield 
 
 
Imp M R2-25 CHEATER 
 
Project title:  An evaluation of the effectiveness and cost effectiveness of  
   audit and feedback and educational outreach in improving  
   nursing practice and health care outcomes 
 
Lead researcher: Dr Francine Cheater, University of Leicester 
 
 
Imp M R2-34 CLARKE 
 
Project title:  Development of evidence-based materials Clinical Guidance  
   Tree, Decision Board & Leaflet for decision-making in  
   Prophylactic Oophorectomy 
 
Lead researcher: Dr Aileen Clarke, London School of Hygiene & Tropical  
Medicine 
 
 
Imp M R2-64 PITTS 
 
Project title:  Effective practice: a randomised trial of dissemination and  
   implementation strategies for guidelines for the appropriate  
   extraction of third molar teeth 
 
Lead researcher: Professor Nigel Pitts, University of Dundee 
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Appendix 3: Questionnaire to Lead Researchers 
 
 
 
NHS R&D IMPLEMENTATION METHODS PROGRAMME : 
 
QUESTIONNAIRE FOR PROGRAMME EVALUATION 
 
 
 
 
Project Title:  
 
Project Reference No:  
 
Lead Researcher:  
 
 
 
Where relevant, please first check the pre-completed information in Section A about 
the publications from your project, which are mostly those taken from the ones listed 
in the Programme Report 2000.  Please answer the questions about these 
publications and then complete the remaining sections using additional sheets if 
necessary.  
 
 
Please return all sections (A-H) together with this sheet, and copies of all your 
peer-reviewed journal articles from the project, by 7 June 2002 to the Health 
Economics Research Group, Brunel University, Uxbridge, UB8 3PH, using the 
pre-paid envelope enclosed.   
 
It is hoped that a version of the final evaluation report, and of the end of programme 
report, will be made available on the SDO web-site, and that a copy of either the 
evaluation, or a summary, will be sent to you.  The focus of the evaluation, however, 
is the programme as a whole rather than the performance of individual research 
teams. 
 
If you have any questions about completing the questionnaire please contact Dr 
Steve Hanney on 01895 203196 ext 3709, email: stephen.hanney@brunel.ac.uk 
 
 
 
Thank you for your assistance.
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A. PREVIOUSLY NOTIFIED PUBLICATIONS  
 
 
 
A1. Please check the publications listed and: 
1. delete any that were not, at least partially, a result of specific funding from 
this programme;  
2. for each publication please tick the appropriate box about programme 
funding acknowledgement;  
3. please use one of the following letters to categorise each publication, and 
add a ‘w’ after the letter if it was a publication available ONLY on the web: 
 
 a = peer-reviewed journal article      b = journal editorial  c = journal letter 
 d = published abstract       e = book   f = chapter 
 g = non-peer reviewed article      h = published conference proceedings  
i  = publicly available full report      j  = other (please specify) 
 
 
Programme Funding 
Acknowledged 
Category 
Yes No 
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B. PUBLICATIONS NOT PREVIOUSLY LISTED 
 
 
 
B1. Please list any additional publications that have resulted directly or indirectly 
from the project.  Include any accepted publications that are in press but not 
any that are only at the submitted stage.  For each publication please: 
1. tick the box on programme funding acknowledgement; and  
2. use one of the following letters to categorise it, and add a ‘w’ after the 
letter if it was a publication available ONLY on the web: 
 
 a = peer-reviewed journal article      b = journal editorial  c = journal letter 
 d = published abstract       e = book   f = chapter 
 g = non-peer reviewed article      h = published conference proceedings  
i  = publicly available full report       j = other (please specify) 
  
 Programme 
Funding 
Acknowledged 
Category 
Yes No 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. POTENTIAL USERS OF THE RESEARCH 
 
 
NB. In answering this question please DO NOT refer to actual use of the 
findings as this forms the basis of later questions. 
 
C1. Please list any groups who at the start of the project, or during it, were viewed 
as potential users of the research findings.  Please list the groups in 
approximate order of importance as potential users of your research.  
Examples of groups you may wish to list include: the research community, 
NHS managers, specific professional bodies, specific groups of clinicians, 
specific patient groups, the general public, and collaborations. 
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D. USE OF THE RESEARCH IN THE RESEARCH SYSTEM 
 
 
D1. Has participation in the research led to additional formal qualifications for any  
members of the project team or is it likely to do so? Yes   No  
 
 If so, please give details. 
 
Qualification Year Contribution from specific project 
 Gained Expected Considerable Moderate Small 
 
 
 
 
 
     
 
D2. Have the project findings or methodology or theoretical developments 
generated subsequent research by members of the team?  
 Yes  No  
 
If so, please give details of further grants, if any, and describe the contribution 
of your original project to securing these funds. 
 
Funder Amount The importance of the project to securing 
later funding 
  Considerable Moderate Small 
 
 
 
 
 
 
    
 
D3. If you are aware of any significant ways in which your project in the 
Implementation Methods Programme has contributed to further research 
conducted by others, please indicate. 
 
Research Team Project title/topic The importance of your project to the 
further research 
  Considerable Moderate Small 
 
 
 
 
 
 
    
 
D4. Please describe any contribution to further research that you have listed in D2 
or D3 that is of particular importance. 
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E. USE OF RESEARCH FINDINGS IN HEALTH SYSTEM POLICY/DECISION MAKING 
 
 
NB.  Questions about applications of the findings by practitioners etc 
form the next section. 
 
E1. Research findings can be used in policy making at any level (eg. national, 
regional, local trust or unit, professional, administrative or managerial) of the 
health service1. 
 
 Have the findings from your project already been used in any such ways? 
Yes   No  
 
 
E2. Are there any reasons for expecting the findings to be used for future 
policy/decision making.        Yes
  No  
 
E3. If you have replied Yes to either E1 or E2 please give details of the use 
and/or expected use including: the level at which policies/decisions were 
influenced; the importance of the project’s findings to the adoption of the 
policy(ies); and any supporting evidence1 – please attach documents where 
relevant or give references to them. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
1
  Evidence of the policy relevance could take many forms including: statements by policy makers; 
citing of the findings in a Health Service Circular, Chief Executive Bulletin or in a clinical guideline 
from a national or local professional group; inclusion of the findings in a contract or in a document 
from an audit, an inspectorial or an evaluative body; the establishment of a working group to examine 
the implications or implementation of the findings etc. 
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F. APPLICATION OF THE PROJECT FINDINGS THROUGH CHANGED BEHAVIOUR 
 
 
 
F1. Have the findings from your project already led to changes, either directly or 
through the application of research-informed policies, in the behaviour of 
practitioners, managers etc, or in the involvement of health service users or 
the wider public? 
Yes   No  
 
F2. Do you expect the findings to influence practitioner or managerial behaviour 
or involvement of health service users or the public in the future?  
 Yes  No  
 
F3. If you replied Yes to either F1 or F2 please specify: the level at which any 
change occurred (eg. local-institution, local-network, regional, national); how 
important the research findings were in changing behaviour; and any 
evidence (such as surveys of practitioners) to support claims that such 
changes in behaviour were caused by the research findings – please attach 
documents where relevant or give references to them. 
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G. FACTORS INFLUENCING THE UTILISATION OF RESEARCH : DISSEMINATION ETC 
 
 
 
G1. Please state approximately how many conference/workshop presentations 
have been made based on the research findings to: 
 
  Primarily academic audiences:    
 .......... 
   
Primarily practitioner/service user audiences:  
 .......... 
   
 
G2. Describe any of these presentations, or any other dissemination activities, 
that were particularly important in achieving utilisation of the project’s findings. 
 
 
 
 
 
 
 
 
G3. Was liaison with potential users a factor in actual or future research 
utilisation?  
  Liaison before starting  Yes   No  
  Liaison during the project  Yes  No  
 
 
G4. Please describe any aspects of such liaison and interaction that are 
particularly important. 
 
 
 
 
 
 
 
 
G5. Describe any other factors (other than ones connected to the overall 
programme) that account for the research being utilised, or for the lack of 
utilisation.  These could include the timeliness or quality of the research, the 
research findings being taken up by the key stakeholders etc. 
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H. THE ROLE OF THE PROGRAMME 
 
 
 
NB.  THIS SECTION OF THE QUESTIONNAIRE WILL NOT BE MADE 
AVAILABLE TO THE SDO 
 
 
H1. Did the fact that your project was part of a programme have any impact on your 
project?  
 
  Not at all    
  A little    
  Moderately   
  Considerably   
  Extensively      
 
 
H2. Did you request, and/or receive, any assistance from the programme commissioning 
group or office with: 
           REQUEST HELP       RECEIVE HELP 
  Completing the application form  Yes   Yes  
  Development of your proposal  Yes   Yes  
  Technical issues during the research Yes   Yes  
Dissemination    Yes   Yes  
 
 
 If you said Yes to any item please explain and also explain whether there 
were any advantages in being part of a wider programme of projects. 
 
 
 
 
 
 
 
H3. What are your views about the commissioning process used in the 
programme? 
 
 
 
 
 
 
 
 
 
H4. How, if at all,  could the commissioning process have been improved? 
 
 
 
 
 
  75     
H5. Have you read of the results of any other projects from the programme?   
        Yes   No  
 If so, how many: ____________ 
 
 
 Have you attended presentations about any other projects from the 
programme? 
Yes  No  
 
 If so, how many: ____________ 
 
 
H6. Do you think an attempt should be made to synthesise the findings from the 
programme? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H7. Please use the space below if you wish to make any further comments about 
your project, the Implementation Methods Programme, or this questionnaire. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
THANK YOU FOR YOUR ASSISTANCE. 
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Appendix 4: Electronic Questionnaire to CHAIN Members with an 
Interest in Women’s Health 
 
 
 
Dear CHAIN member, 
 
Evaluation of the NHS R&D Implementation Methods Programme: Projects 
Related to Women’s Health. 
 
We are seeking your views as part of the assessment of a major R&D programme 
aimed at enhancing effective health care.  
 
The SDO now have responsibility for the NHS’s R&D Implementation Methods 
Programme. Most of the programme’s projects are now finished, therefore the SDO 
have commissioned the Health Economics Research Group at Brunel University to 
conduct an evaluation. This is intended to inform thinking about issues such as 
research commissioning in this field. 
 
One element of the evaluation is to gather the views of potential users of the 
programme about its value in their field. Attached is a one page questionnaire 
followed by brief details of five projects, out of the 36 commissioned by the 
programme, that could be classified as relating to Women’s Health. (Projects were 
selected for funding on the basis of their approach to studying research 
implementation. It seems appropriate, however, for the evaluation to seek the views 
of reasonably coherent groups of potential users based on their medical field or 
professional grouping.) 
 
We hope you would be willing to read the enclosed brief, one page, details of each of 
the five projects, and then complete the single questionnaire that covers all the 
projects using the ID number given to each project. 
 
The answers will be treated in the strictest confidence and neither the project data-
base, nor the final report, will identify any respondents. Information about this 
evaluation will be available in a few months time on the SDO web site.  
 
Please return your answers to me by 20 September by: 
fax (01895 203330);  
post (HERG, Brunel University, Uxbridge, UB8 3PH); 
or email: stephen.hanney@brunel.ac.uk  
 
Please contact me if you have any queries about the questionnaire. 
 
Best Wishes 
 
 
 
Dr. Stephen Hanney. 
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QUESTIONNAIRE 
 
 
PLEASE ANSWER THESE QUESTIONS USING THE  I .D. NUMBER GIVEN TO 
THE ATTACHED PROJECTS. 
 
 
1. Had you previously heard about the NHS R&D Implementation Methods 
Programme: 
 
2. Regardless of whether your answer to the above question is yes or no, please 
give the ID numbers of any of the five projects from the Programme, listed 
overleaf,  about which you had previously heard: 
 
3. List the ID numbers of any of these six projects from which you had read either 
the article described in the abstract or a different article: 
 
4. List the ID numbers of any projects whose findings have already influenced:                                           
a) Your clinical practice:                          
b) Your research:                                                
c) Your teaching: 
 
5. List the ID numbers of any projects whose findings you expect to influence:                                           
a) Your clinical practice:                            
b) Your research:                                                  
c) Your teaching:                                                 
 
6. If you have not used, or do not intend to use,  the findings from any projects 
relevant to your area of work, please give your reasons: 
 
 
 
 
 
 
7. List the ID numbers of any projects you think already have been, or will be, used 
by others to make a contribution to enhancing effective health care: 
 
 
8. Please state your role(s) in relation to the health service (such as, midwife, nurse, 
consultant, university-based researcher, member of an advocacy group): 
 
 
9. Please make any other comments you wish about the Implementation Methods 
Programme: 
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No. 1: 
 
EFFECTIVE COMMUNICATION: AN EVALUATION OF TOUCHSCREEN DISPLAYS FOR 
PROVIDING INFORMATION ON PRENATAL DIAGNOSIS 
 
Lead Researcher: Dr A Pat Smith  Aberdeen Royal Hospitals NHS Trust 
 
 
Project Summary: 
Touchscreen information packages are already used in a variety of situations to facilitate 
public access to details on a huge variety of topics.  One area of particular need is adequate, 
accessible and appropriate information for women and their partners on prenatal diagnostic 
tests.  A touchscreen system to meet this need has recently been developed in Aberdeen. 
 
The objectives of the proposed study are to evaluate the effectiveness of this touchscreen at 
providing information, to determine its acceptability to women, and to measure its impact on 
informed decision-making regarding prenatal diagnostic tests.  A randomised controlled trial 
will be conducted, with one group of women exposed to the touchscreen and supporting 
information leaflet and the other receiving only the leaflet. 
 
 
ARTICLE: 
RANDOMISED CONTROLLED TRIAL COMPARING EFFECTIVENESS OF TOUCH 
SCREEN SYSTEM WITH LEAFLET FOR PROVIDING WOMEN WITH INFORMATION ON 
PRENATAL TESTS 
 
Wendy Graham, Pat Smith, A Kamal, A Fitzmaurice, N Smith, N Hamilton 
BMJ,  320: 155-6 (15 January 2000) 
 
Abstract:…………………………. 
 
 
No. 2: 
 
UPTAKE OF EFFECTIVE PRACTICES IN MATERNITY UNITS 
 
Lead Researcher:  Dr Jenny Hewison  University of Leeds 
 
Project Summary: 
This is a national study of changes in adherence to four obstetric care standards over time, 
conducted in 20 hospitals selected at random.  It has two objectives, to estimate adherence to 
standards which are strongly supported by evidence from a well publicised database of 
systematic reviews (the Cochrane Database and its electronic and published precursors); and 
to relate this quality measurement to the knowledge and attitudes of clinicians, and to the 
rigour of the procedures established for implementing change.  The standards are:  use of 1) 
prophylactic antibiotics for Caesarian Section,  2) steroids when pre-term delivery can be 
anticipated,  3) the ventouse for instrumental delivery,  4) suture material used to repair 
episiotomy, and 5) the management of eclampsia.  Current levels of adherence will be placed 
in the context of past performance.  The results will determine the scope for further 
improvement and indicate topics for intervention studies.  
 
 
ARTICLE: 
THE LEEDS UNIVERSITY MATERNITY AUDIT PROJECT 
 
B Wilson, J G Thornton, J Hewison, R J Lilford, I Watt, D Braunholtz, M Robinson 
International Journal for Quality in Health Care, 14: 175-181 (2002) 
 
Abstract:………………………..  
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No. 3: 
  
EVALUATION OF INFORMED CHOICE LEAFLETS IN MATERNITY CARE 
 
Lead Researcher:     Professor Mavis Kirkham         University of Sheffield 
 
Project Summary: 
A study to evaluate the use of the informed choice leaflets in maternity care by means of: 
• Mapping present use; 
• An ethnographic study of 3 differing sites of current use; 
• A 12 site RCT in Wales. 
 
This will measure outcomes in terms of knowledge, attitudes, psychological, emotional and 
physical outcomes and relevant organisational and economic factors. 
Qualitative work within the RCT will examine the process of leaflet prescription and use.  
Tools will be developed for local use – monitoring and assessing leaflets in use 
The results will be likely to be useful in many areas concerned with informed choice and of 
wider significance in maternity care. 
 
Funded jointly with the Central R & D programme. 
 
 
ARTICLE: 
QUALITATIVE STUDY OF EVIDENCE BASED LEAFLETS IN MATERNITY CARE 
 
Helen Stapleton, Mavis Kirkham, Gwenan Thomas 
BMJ, 324: 639-643  (16 March 2002) 
 
Abstract:…………………….. 
 
No. 4:  
THE ROLE OF THE MEDIA IN PUBLIC AND PROFESSIONAL UNDERSTANDING OF 
BREAST CANCER 
 
Lead researcher:  Dr  Jenny Kitzinger  University of Glasgow 
 
Project Summary: 
This proposal is to examine the operation of the media and their influence on public and 
professional understanding of breast cancer.  The research develops simultaneously on three 
levels. 
 
1. Production processes involving interviews with journalists/health 
correspondents/sources. 
2. A detailed examination of media content. 
3. The use of focus groups to examine how new information is received and understood. 
 
A key objective is to show why some messages on new research or related issues are taken 
up by the media and the impact of this on belief and understanding.  This will provide relevant 
information on the potential success of different publicity strategies. 
 
ARTICLE: 
 
THE HUMAN DRAMA OF GENETICS:  ‘HARD’ AND ‘SOFT’ MEDIA REPRESENTATIONS 
OF INHERITED BREAST CANCER 
 
Lesley Henderson, Jenny Kitzinger  
Sociology of Health and Illness, 21: 560-578  (1999) 
 
Abstract:…………………………. 
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No. 5: 
 
DEVELOPMENT OF EVIDENCE-BASED MATERIALS; CLINICAL GUIDANCE TREE, 
DECISION BOARD, AND LEAFLET FOR DECISION MAKING IN PROPHYLACTIC 
OOPHORECTOMY – PO 
 
Lead researcher:  Dr Aileen Clarke London School of Hygiene and Tropical Medicine 
 
Project Summary: 
To develop a Clinical Guidance Tree – an evidence-based decision making aid which will 
allow patients and clinicians to take account both of available evidence and of patients’ values 
using a computerised interactive decision tree with information presented and elicited in 
accessible formats.  To develop a decision board and a patient information leaflet using the 
same information as for the Clinical Guidance Tree.  To pilot and undertake preliminary 
feasibility and evaluation studies of the three forms of decision aid in PO.  Outcomes 
investigated will include several measures of the overall quality of the decision made;  
including an in-depth qualitative assessment of patient and doctor satisfaction and measures 
of decisional conflict and anxiety, extent of information coverage and exchange, satisfaction 
with the decision and an assessment of the relationship of the decision made to predicted 
health gain.  Results will be applicable to the process of implementation of best evidence and 
to practical decision-making in a number of common conditions besides PO, e.g. chronic 
diseases such as asthma, diabetes and hypertension and will also indicate the costs and 
benefits of the process of incorporating patients’ values into evidence-based decision making. 
 
 
ARTICLE: 
 
WOMEN’S VIEWS OF TWO INTERVENTIONS DESIGNED TO ASSIST IN THE 
PROPHYLACTIC OOPHORECTOMY DECISION: A QUALITATIVE PILOT EVALUATION 
 
Vanita Bhavani, Aileen Clarke, Jack Dowie, Andrew Kennedy,Ian Pell 
Health Expectations, 5: 156-171 (2001) 
 
Abstract:…………………………………….. 
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Appendix 5: Electronic Questionnaire to CHAIN Members with an 
Interest in the Management of Heart Disease 
 
 
Dear CHAIN member, 
 
Evaluation of the NHS R&D Implementation Methods Programme: Projects Related 
to the Management of Heart Disease. 
 
We are seeking your views as part of the assessment of a major R&D programme 
aimed at enhancing effective health care.  
 
The SDO now have responsibility for the NHS’s R&D Implementation Methods 
Programme. Most of the programme’s projects are now finished, therefore the SDO 
have commissioned the Health Economics Research Group at Brunel University to 
conduct an evaluation. This is intended to inform thinking about issues such as 
research commissioning in this field. 
 
One element of the evaluation is to gather the views of potential users of the 
programme about its value in their field. Attached is a one page questionnaire 
followed by brief details of three projects, out of the 36 commissioned by the 
programme, that could be classified as relating to the management of heart 
disease—one is on the general theme of information for patients, but included heart 
disease as one of its areas of study. (Projects were selected for funding on the basis 
of their approach to studying research implementation. It seems appropriate, 
however, for the evaluation to seek the views of reasonably coherent groups of 
potential users based on their medical field or professional grouping.) 
 
We hope you would be willing to read the enclosed brief, one page, details of each of 
the three projects, and then complete the single questionnaire that covers all the 
projects using the ID number given to each project. 
 
The answers will be treated in the strictest confidence and neither the project data-
base, nor the final report, will identify any respondents. Information about this 
evaluation will be available in a few months time on the SDO web site. 
 
Please return your answers to me by 20 September: 
by fax (01895 203330); 
post (HERG, Brunel University, Uxbridge, UB8 3PH); 
or email: stephen.hanney@brunel.ac.uk  
 
Please contact me if you have any queries about the questionnaire. 
 
Best Wishes 
 
 
 
Dr. Stephen Hanney. 
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QUESTIONNAIRE 
 
 
PLEASE ANSWER THESE QUESTIONS USING THE  I .D. NUMBER GIVEN TO 
THE ATTACHED PROJECTS. 
 
 
1. Had you previously heard about the NHS R&D Implementation Methods 
Programme: 
 
2. Regardless of whether your answer to the above question is yes or no, please 
give the I D numbers of any of the three projects from the Programme, listed 
overleaf,  about which you had previously heard: 
 
3. List the I D numbers of any of these three projects from which you had read either 
the article or letter described in the abstract/summary/extract or a different 
publication: 
 
4. List the I D numbers of any projects whose findings have already influenced:                                           
a) Your clinical practice:                            
b) Your research:                                                  
c) Your teaching:                                                 
 
5. List the I D numbers of any projects whose findings you expect to influence:                                           
a) Your clinical practice:                            
b) Your research:                                                  
c) Your teaching:                                                 
 
6. If you have not used, or do not intend to use,  the findings from any projects 
relevant to your area of work, please give your reasons: 
 
 
 
 
 
 
7. List the I D numbers of any projects you think already have been, or will be, used 
by others to make a contribution to enhancing effective health care: 
 
 
8. Please state your role(s) in relation to the health service (such as, GP, nurse, 
consultant, university-based researcher, member of an advocacy group): 
 
 
9. Please make any other comments you wish about the Implementation Methods 
Programme: 
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No. 1: 
EVIDENCE BASED SECONDARY PREVENTION OF HEART DISEASE IN PRIMARY 
CARE: A RANDOMISED CONTROLLED TRIAL OF THREE METHODS OF 
IMPLEMENTATION 
 
Lead Researcher:  Dr Theo Schofield University of Oxford 
 
Project Summary: 
Aims:  1.  To compare in a randomised controlled trial of 18 general practices three methods 
of promoting change in primary care;  audit and feedback;  the introduction of structured 
records, registers and recall;  the introduction of nurse run clinics.     2.   To evaluate within 
practice by randomised controlled trials the effectiveness of structured recall and nurse run 
clinics in changing the risk factor status and treatment of patients with known ischaemic heart 
disease. 
 
ARTICLE:  
CLUSTER RANDOMISED CONTROLLED TRIAL TO COMPARE THREE METHODS OF 
PROMOTING SECONDARY PREVENTIONOF CORONARY HEART DISEASE IN PRIMARY 
CARE 
 
Michael Moher, Patricia Yudkin, Lucy Wright, Rebecca Turner, Alice Fuller, Theo Schofield, 
David Mant for the Assessment of Implementation Strategies (ASSIST) Trial Collaborative 
Group. 
BM J,  322: 1338-1342 (2 June 2001) 
 
Abstract:………………………………… 
  
No. 2 
COMMUNICATING RISK REDUCTION TO PATIENTS AND CLINICIANS IN THE 
SECONDARY PREVENTION OF ISCHAEMIC HEART DISEASE:  PERSPECTIVES OF 
INNERCITY PATIENTS, GENERAL PRACTITIONERS AND PRACTICE NURSES 
 
Lead Researcher:  Professor Gene Feder  
St Bartholomew’s Royal London Hospital Medical and Dental School  
 
Project Summary: 
This multidisciplinary qualitative study builds on an ongoing prospective randomised 
controlled trial testing the ability of guideline-derived postal prompts to survivors of myocardial 
infarction and their GPs to increase uptake of secondary prevention in innercity primary care.  
Prompts to patients and their GPs used in this study contain detailed risk reduction 
information.  Semi-structured interviews of patients, GPs and nurses will determine: 
• Levels of understanding and acceptability of providing risk reduction information in 
different forms to a group of high risk patients and their GPs in an innercity environment. 
• Perceived relevance of this information to innercity patients and clinicians and its potential 
to influence cooperative behaviour between the two, taking into account the patients’ own 
context (eg. Health beliefs, ethnicity, age). 
• Potential acceptability and preference for alternative forms of written presentation of risk 
reduction 
 
LETTER: 
MANAGING ESTABLISHED CORONARY HEART DISEASE: PRACTICE TEAMS NEED 
SUPPORT IN ORGANISING PHARMACOLOGICAL AND LIFESTYLE  INTERVENTIONS. 
 
Gene Feder, Chris Griffiths, 
BMJ,  316: 309 (24 January 1998) 
Extract:………………………… 
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No. 3 
AVAILABILITY OF INFORMATION MATERIALS TO PROMOTE EVIDENCE-BASED 
PATIENT CHOICE 
 
Lead Researcher:  Professor Angela Coulter  King’s Fund 
 
Project Summary: 
A four-stage study to investigate the availability of patient information materials about 
treatment choices for ten conditions for which high quality systematic reviews exist;  to assess 
the materials in terms of scientific validity and acceptability to patients;  to develop guidance 
on the production of patient information;  to provide practical help to health authorities and 
health care providers on evidence-based patients choice. 
 
 
ARTICLE: 
 
SHARING DECISIONS WITH PATIENTS: IS THE INFORMATION GOOD ENOUGH? 
 
Angela Coulter, Vikki Entwistle, David Gilbert 
BMJ,  318: 318-322    (30 January 1999) 
 
Summary points:………………………… 
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Appendix 6: Electronic Questionnaire to Members of a Bulletin Board for 
Researchers into Shared Decision Making 
 
 
 
 
Dear colleague, 
 
Evaluation of the NHS R&D Implementation Methods Programme: Projects Related 
to Shared Decision Making. 
 
We are seeking your views as part of the assessment of a major R&D programme 
aimed at studying the implementation of findings from health research. The UK’s 
NHS R&D Implementation Methods Programme was one of the first major R&D 
programme systematically to address a range of issues related to this topic, including 
various aspects of decision making by clinicians and patients. 
 
Most of the projects are now finished and the Health Economics Research Group at 
Brunel University has been commissioned to conduct an evaluation of the 
programme. This is intended to inform thinking about issues such as future research 
commissioning in this field. 
 
One element of the evaluation is to gather the views of potential users of the 
programme about its value in their field. Various projects identified the research 
community as a target audience for their study. Attached is a one page questionnaire 
followed by brief details of four projects commissioned by the programme that might 
be of most interest to researchers in the field of decision making. We hope you would 
be willing to read the enclosed brief, one page, details of each of the projects, and 
then complete the single questionnaire that covers all the projects using the ID 
number given to each project. 
 
The answers will be treated in the strictest confidence and neither the project data-
base, nor the final report, will identify any respondents. Information about this 
evaluation would be made available from me on request in a few months. 
 
Please return your answers to me by 11 October by: 
fax (+44 [0]1895 203330);  
post (HERG, Brunel University, Uxbridge, UB8 3PH); 
or email: stephen.hanney@brunel.ac.uk  
 
Please contact me if you have any queries about the questionnaire. 
 
Best Wishes 
 
 
Dr. Stephen Hanney. 
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QUESTIONNAIRE 
 
 
PLEASE ANSWER THESE QUESTIONS USING THE  I .D. NUMBER GIVEN TO 
THE ATTACHED PROJECTS. 
 
 
1. Had you previously heard about the UK’s NHS R&D Implementation Methods 
Programme: 
 
2. Regardless of whether your answer to the above question is yes or no, please 
give the ID numbers of any of the four projects from the Programme, listed 
overleaf,  about which you had previously heard through publications, conference 
presentations etc: 
 
3. List the ID numbers of any of these  projects from which you had read either the 
article described in the abstract or a different article: 
 
4. List the ID numbers of any projects whose findings have already influenced:                                       
a) Your research:  
b) Your clinical practice:                                                                        
c) Your teaching: 
 
5. List the ID numbers of any projects whose findings you expect to influence:                                           
a) Your research:                                                  
b) Your clinical practice:                            
c) Your teaching:                                                 
 
6. If you have not used, or do not intend to use,  the findings from any projects 
relevant to your area of work, please give your reasons: 
 
 
 
 
 
 
7. List the ID numbers of any projects you think already have been, or will be, used 
by others: 
 
8. Please make any other comments you wish about the potential contribution that 
could be made by the projects in this programme: 
 
 
 
 
 
 
 
 
 
THANK YOU FOR YOUR ASSISTANCE 
 
 
 
  87     
No. 1: 
EFFECTIVE COMMUNICATION: AN EVALUATION OF TOUCHSCREEN DISPLAYS FOR 
PROVIDING INFORMATION ON PRENATAL DIAGNOSIS 
 
Research team: Wendy Graham, Pat Smith, A Kamal, A Fitzmaurice, N Smith, N Hamilton 
Aberdeen Royal Hospitals NHS Trust 
Project Summary: 
Touchscreen information packages are already used in a variety of situations to facilitate 
public access to details on a huge variety of topics.  One area of particular need is adequate, 
accessible and appropriate information for women and their partners on prenatal diagnostic 
tests.  A touchscreen system to meet this need has recently been developed in Aberdeen. 
The objectives of the proposed study are to evaluate the effectiveness of this touchscreen at 
providing information, to determine its acceptability to women, and to measure its impact on 
informed decision-making regarding prenatal diagnostic tests.  A randomised controlled trial 
will be conducted, with one group of women exposed to the touchscreen and supporting 
information leaflet and the other receiving only the leaflet. 
 
ARTICLE: 
RANDOMISED CONTROLLED TRIAL COMPARING EFFECTIVENESS OF TOUCH 
SCREEN SYSTEM WITH LEAFLET FOR PROVIDING WOMEN WITH INFORMATION ON 
PRENATAL TESTS 
 
Wendy Graham, Pat Smith, A Kamal, A Fitzmaurice, N Smith, N Hamilton 
BMJ,  320: 155-6  (15 January 2000) 
 
Abstract:………………………………… 
 
No. 2:  
DEVELOPMENT OF EVIDENCE-BASED MATERIALS; CLINICAL GUIDANCE TREE, 
DECISION BOARD, AND LEAFLET FOR DECISION MAKING IN PROPHYLACTIC 
OOPHORECTOMY – PO 
 
Research team: Jack Dowie, Aileen Clarke, Andrew Kennedy, Ian Pell, Vanita Bhavnani 
London School of Hygiene and Tropical Medicine 
 
Project Summary: 
To develop a Clinical Guidance Tree – an evidence-based decision making aid which will 
allow patients and clinicians to take account both of available evidence and of patients’ values 
using a computerised interactive decision tree with information presented and elicited in 
accessible formats.  To develop a decision board and a patient information leaflet using the 
same information as for the Clinical Guidance Tree.  To pilot and undertake preliminary 
feasibility and evaluation studies of the three forms of decision aid in PO.  Outcomes 
investigated will include several measures of the overall quality of the decision made;  
including an in-depth qualitative assessment of patient and doctor satisfaction and measures 
of decisional conflict and anxiety, extent of information coverage and exchange, satisfaction 
with the decision and an assessment of the relationship of the decision made to predicted 
health gain.  Results will be applicable to the process of implementation of best evidence and 
to practical decision-making in a number of common conditions besides PO, e.g. chronic 
diseases such as asthma, diabetes and hypertension and will also indicate the costs and 
benefits of the process of incorporating patients’ values into evidence-based decision making. 
 
ARTICLE: 
DEVELOPMENT AND PRELIMINARY EVALUATION OF A CLINICAL GUIDANCE 
PROGRAMME FOR THE DECISION ABOUT PROPHYLACTIC OOPHORECTOMY IN 
WOMEN UNDERGOING A HYSTERECTOMY 
 
I Pell, J Dowie, A Clarke, A Kennedy, V Bhavnani 
Quality and Safety in  Health Care, 11: 32-39 (2002) 
 
Abstract:…………………………….. 
  88     
No. 3 
 
AVAILABILITY OF INFORMATION MATERIALS TO PROMOTE EVIDENCE-BASED 
PATIENT CHOICE 
 
Researcher team: Angela Coulter, Vikki Entwistle, David Gilbert          King’s Fund 
 
Project Summary: 
A four-stage study to investigate the availability of patient information materials about 
treatment choices for ten conditions for which high quality systematic reviews exist;  to assess 
the materials in terms of scientific validity and acceptability to patients;  to develop guidance 
on the production of patient information;  to provide practical help to health authorities and 
health care providers on evidence-based patients choice. 
 
 
ARTICLE: 
 
SHARING DECISIONS WITH PATIENTS: IS THE INFORMATION GOOD ENOUGH? 
 
Angela Coulter, Vikki Entwistle, David Gilbert 
BMJ, 318: 318-322   (30 January 1999) 
 
Summary points:…………………………….. 
 
 
No. 4 
 
A SYSTEMATIC REVIEW OF RISK COMMUNICATION – IMPROVING EFFECTIVE 
CLINICAL PRACTICE AND RESEARCH IN PRIMARY CARE  
 
Research team:  Adrian Edwards, Kerenza Hood, Elaine Matthews, Daphne Russell,  
IanRussell, Jacqueline Barker, Michael Bloor, Philip Burnard, Judith Covey, Roisin Pill, Clare 
Wilkinson, Nigel Stott.  
University of Wales College of Medicine. 
 
Project Summary: 
The study of risk communication involves consideration of the characteristics of the 
communicator;  the nature of the communication and the methods used to convey it;  and the 
characteristics of the target person.  The review will seek medical, nursing and social science 
literature for theoretical models and evidence from risk communication studies.  
It will focus on general practice based primary care and on “one-to-one” communication.  The 
principal aim is to produce up-to-date guidance to improve clinician/patient communication on 
issues such as risk status, risks involved with screening and treatment procedures etc.  This 
would enable better use of available research findings and thus facilitate more cost-effective 
health care.  Subsidiary aims are:  (1) to identify a future research agenda for risk 
communication in primary care and (2) to establish a database of qualitative literature on risk 
communication studies.  
 
ARTICLE: 
 
THE EFFECTIVENESS OF ONE-TO-ONE RISK-COMMUNICATION INTERVENTIONS IN 
HEALTH CARE:A SYSTEMATIC REVIEW  
 
Adrian Edwards, Kerenza Hood, Elaine Matthews, Daphne Russell,  Ian Russell, Jacqueline 
Barker, Michael Bloor, Philip Burnard, Judith Covey, Roisin Pill, Clare Wilkinson, Nigel Stott. 
Medical  Decision  Making,  20: 290-297 (2000) 
 
Abstract:………………………………….. 
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Appendix 7: Questionnaire to Heads of Midwifery and Researchers in the 
Maternity Care Field 
 
 
 
 
 
Dear colleague, 
 
Evaluation of the NHS R&D Implementation Methods  
Programme: Projects Related to Maternity Care. 
 
We are seeking your views as part of the assessment of a major R&D programme 
aimed at enhancing effective health care.  
 
The National Co-ordinating Centre for NHS Service Delivery and Organisation R&D 
(NCCSDO) now have responsibility for the NHS’s R&D Implementation Methods 
Programme. Most of the programme’s projects are now finished, therefore the Health 
Economics Research Group at Brunel University was commissioned to conduct an 
evaluation. This is intended to inform thinking about issues such as research 
commissioning in this field. 
 
One element of the evaluation is to gather the views of potential users of the 
programme about its value in their field. Attached is a one page questionnaire 
followed by brief details of three projects, out of the 36 commissioned by the 
programme, that could be classified as relating to maternity care (Projects were 
selected for funding on the basis of their approach to studying research 
implementation. It seems appropriate, however, for the evaluation to seek the views 
of reasonably coherent groups of potential users based on their medical field or 
professional grouping.) 
 
We hope you would be willing to read the enclosed brief, one page, details of each of 
the three projects, and then complete the single questionnaire that covers all the 
projects using the ID number given to each project. 
 
The answers will be treated in the strictest confidence and neither the project 
database, nor the final report, will identify any respondents. Information about this 
evaluation will be available in a few months time on the NCCSDO web site.  
 
Please return your answers to me by 23 October using the enclosed prepaid 
envelope. 
 
Please contact me if you have any queries about the questionnaire. 
 
Best Wishes 
 
 
 
Dr. Stephen Hanney. 
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PLEASE ANSWER THESE QUESTIONS USING THE  I .D. NUMBER GIVEN 
TO THE ATTACHED PROJECTS. 
 
 
1. Had you previously heard about the NHS R&D Implementation Methods 
Programme: 
Yes                                    No  
 
2. Regardless of whether your answer to the above question is yes or no, please 
give the ID numbers of any of the three projects from the Programme, listed 
overleaf,  about which you had previously heard: 
___________________________ 
 
3. List the ID numbers of any of these three projects from which you had read 
either the article described in the abstract or a different article: 
___________________________ 
 
4. List the ID numbers of any projects whose findings have already influenced:                                           
a) The clinical practice of yourself or your unit:  _________________________                       
b) Your research:  ________________________________________________                                               
c) Your teaching:  ________________________________________________ 
 
5. List the ID numbers of any projects whose findings you expect to influence:                                           
a) The clinical practice of yourself or your unit:  _________________________                         
b) Your research:  ________________________________________________                                                 
c) Your teaching:  ________________________________________________                                              
 
6. If you have not used, or do not intend to use,  the findings from any projects 
relevant to your area of work, please give your reasons: 
_____________________________________________________________ 
 
_____________________________________________________________ 
 
_____________________________________________________________ 
 
 
7. List the ID numbers of any projects you think already have been, or will be, used 
by others to make a contribution to enhancing effective health care: 
_______________________ 
 
8. Please state your role(s) in relation to the health service (such as, midwife, 
university-based researcher):  _______________________ 
 
9. Please make any other comments you wish about the Implementation Methods 
Programme:  
_____________________________________________________________ 
 
_____________________________________________________________ 
 
_____________________________________________________________ 
 
 
 THANK YOU FOR YOUR ASSISTANCE AND PLEASE RETURN THE QUESTIONNAIRE USING 
THE PREPAID ENVELOPE TO: 
 
DR. S. HANNEY, HERG, BRUNEL UNIVERSITY, UXBRIDGE, UB8 3PH   
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No. 1: 
 
EFFECTIVE COMMUNICATION: AN EVALUATION OF TOUCHSCREEN DISPLAYS FOR 
PROVIDING INFORMATION ON PRENATAL DIAGNOSIS 
 
Lead Researcher: Dr A Pat Smith  Aberdeen Royal Hospitals NHS Trust 
 
 
Project Summary: 
Touchscreen information packages are already used in a variety of situations to facilitate 
public access to details on a huge variety of topics.  One area of particular need is adequate, 
accessible and appropriate information for women and their partners on prenatal diagnostic 
tests.  A touchscreen system to meet this need has recently been developed in Aberdeen. 
 
The objectives of the proposed study are to evaluate the effectiveness of this touchscreen at 
providing information, to determine its acceptability to women, and to measure its impact on 
informed decision-making regarding prenatal diagnostic tests.  A randomised controlled trial 
will be conducted, with one group of women exposed to the touchscreen and supporting 
information leaflet and the other receiving only the leaflet. 
 
 
ARTICLE: 
 
RANDOMISED CONTROLLED TRIAL COMPARING EFFECTIVENESS OF TOUCH 
SCREEN SYSTEM WITH LEAFLET FOR PROVIDING WOMEN WITH INFORMATION ON 
PRENATAL TESTS 
 
Wendy Graham, Pat Smith, A Kamal, A Fitzmaurice, N Smith, N Hamilton 
BMJ,  320: 155-6  (15 January 2000) 
 
Abstract:………………………………… 
 
No. 2: 
 
UPTAKE OF EFFECTIVE PRACTICES IN MATERNITY UNITS 
 
Lead Researcher:  Dr Jenny Hewison  University of Leeds 
 
Project Summary: 
This is a national study of changes in adherence to four obstetric care standards over time, 
conducted in 20 hospitals selected at random.  It has two objectives, to estimate adherence to 
standards which are strongly supported by evidence from a well publicised database of 
systematic reviews (the Cochrane Database and its electronic and published precursors); and 
to relate this quality measurement to the knowledge and attitudes of clinicians, and to the 
rigour of the procedures established for implementing change.  The standards are:  use of 1) 
prophylactic antibiotics for Caesarian Section,  2) steroids when pre-term delivery can be 
anticipated,  3) the ventouse for instrumental delivery,  4) suture material used to repair 
episiotomy, and 5) the management of eclampsia.  Current levels of adherence will be placed 
in the context of past performance.  The results will determine the scope for further 
improvement and indicate topics for intervention studies.  
 
ARTICLE: 
 
THE LEEDS UNIVERSITY MATERNITY AUDIT PROJECT 
 
B Wilson, J G Thornton, J Hewison, R J Lilford, I Watt, D Braunholtz, M Robinson 
International Journal for Quality in Health Care, 14: 175-181 (2002) 
 
Abstract:……………………………… 
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No. 3:  
 
EVALUATION OF INFORMED CHOICE LEAFLETS IN MATERNITY CARE 
 
Lead Researcher: Professor Mavis Kirkham   University of Sheffield 
 
Project Summary: 
A study to evaluate the use of the informed choice leaflets in maternity care by means of: 
• Mapping present use; 
• An ethnographic study of 3 differing sites of current use; 
• A 12 site RCT in Wales. 
 
This will measure outcomes in terms of knowledge, attitudes, psychological, emotional and 
physical outcomes and relevant organisational and economic factors. 
Qualitative work within the RCT will examine the process of leaflet prescription and use.  
Tools will be developed for local use – monitoring and assessing leaflets in use. 
The results will be likely to be useful in many areas concerned with informed choice and of 
wider significance in maternity care. 
 
Funded jointly with the Central R & D programme. 
 
 
ARTICLE: 
 
QUALITATIVE STUDY OF EVIDENCE BASED LEAFLETS IN MATERNITY CARE 
 
Helen Stapleton, Mavis Kirkham, Gwenan Thomas.         
BMJ, 324: 639-643  (16 March 2002) 
 
Abstract:…………………………………. 
